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Abstract 
Introduction: Metabolic Syndrome is a collection of clinical signs that represent unfavourable 
metabolic changes in the body. Metabolic syndrome has been associated with increasing risk of 
cardiovascular disease, Type II diabetes mellitus, stroke, and all-cause mortality. In recent years 
sedentary behaviour has been linked to markers of metabolic syndrome, cardiovascular disease and 
all-cause mortality. Research shows that the negative effects of sedentary behaviour are separate 
from the benefits of physical activity and that steps should be taken to mitigate harm by replacing 
sedentary behaviour with regular light intensity physical activity. For example, substituting sitting 
for standing.  
Methods: This single-case design study investigated the effects of a sit-stand or standing 
workstation on physical activity and metabolic markers: central obesity, blood pressure, blood 
glucose, triglycerides and HDL cholesterol. Six occupationally sedentary participants aged between 
25 and 40 years with a BMI between 25 and 30 kg/m2 were recruited from the Auckland population. 
During a 5 week baseline period, a 3 week ‘phase-in’ period and a 13 week intervention period, 
participants were assessed every 4 weeks using anthropometric and biochemical measurements in 
order to analyse any changes to the markers of metabolic syndrome. Inclinometry recorded during 
working hours was used to analyse changes to daily occupational sitting and standing duration. 
Results: Changes occurred for daily sitting and standing time for 5 participants. Standing time 
increased following the introduction of the standing workstation; the smallest increase was 111 
min/day and the largest increase was 341 min/day. The smallest decrease in daily sitting time was 
107 minutes and the largest decrease was 311 min/day. During the intervention period, the changes 
to daily sitting and daily standing times remained stable. Three participants showed decreases in 
waist circumference of between 2.5 and 6.7 cm. Meaningful changes in other metabolic markers 
were only seen in a single increase of blood glucose, and a single decrease of blood triglycerides. 
Conclusion: The use of sit-stand or standing workstations reduced daily occupational sitting and 
increased daily occupational standing in all participants, where inclinometry data were available. 
These changes were stable across the entire intervention period suggesting high acceptability of 
the standing workstation. The failure to detect changes to metabolic markers may be suggestive of 
study limitations, such as duration, or the complexity of metabolic syndrome. Future studies may 
use randomising and control groups with a larger sample. 
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Chapter 1. Metabolic syndrome and sedentary behaviour 
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1.1. Background and aims of this study 
Steady increases in levels of sedentary behaviour in the last 50 years, with decreases in physical 
activity, have led to recognition of three major domains of sitting: transport, work, and leisure time 
(Brownson, Boehmer, & Luke, 2004; Juneau & Potvin, 2010). As a form of sedentary behaviour, 
sitting is more prevalent in young adults and in those with higher levels of education (Bauman et al., 
2011). With a push in Western cultures for tertiary education and an economic climate demanding 
growth, ‘white-collar’ employment such as that found in professional or administrative roles may 
result in employees experiencing many hours of occupational sitting per day. In New Zealand, 50% 
of the population spend at least 4 hours a day in a sedentary state (Bauman et al., 2011). When 
compared to those who sit <2 h/day, those who sit for >4 h/day show increased risks for CVD, T2DM 
and all-cause mortality (Dunstan et al., 2010). The amount of time spent in occupational sedentary 
behaviour is not known for New Zealand. Drawing from Australian data (Mummery, Schofield, 
Steele, Eakin, & Brown, 2005), it is possible that 30% of New Zealand adults in full-time occupation 
spend at least 3.5 hours per day sitting down. In addition, for the 440,000 commuters in the greater 
Auckland metropolitan area, commuting may total between 40 and 80 minutes per day of driving or 
on public transport (Statistics New Zealand, 2013). Combine commuting and occupational sitting, 
with any sedentary time outside of work and it is easy to see that daily sitting time may be high for 
New Zealand working adults.  
Metabolic syndrome (MetS) is a collection of unfavourable clinical signs that occur commonly 
together as a cluster. Although there is some dispute as to its classification, MetS is primarily 
comprised of central obesity, insulin resistance, dyslipidaemia and hypertension (Alberti et al., 
2009; Alberti, Zimmet, & Shaw, 2006; The National Cholesterol Education Program, 2001). The 
development of MetS in individuals is a strong predictor for stroke, cardiovascular disease (CVD), 
Type II diabetes (T2DM) and all-cause mortality (Isomaa et al., 2001; Mottillo et al., 2010). The 
specific prevalence of MetS is not known for the entire New Zealand population; however, 
considering a third of the population are classified as being obese and 1 in 10 are currently receiving 
pharmaceutical treatment for hypertension or hypercholesterolaemia, it is possible that the 
prevalence in New Zealand might be within the range of 15-25% of the adult population. However, 
as the actual prevalence is unknown, objective research is required to further examine the impact of 
MetS. 
Recent data shows that long periods of sedentary behaviour, such as prolonged sitting, are 
correlated with unhealthy changes to the markers of MetS including raised BMI (Mummery et al., 
2005), raised waist circumference, high blood pressure, decreased HDL cholesterol (Wijndaele et al., 
2009), increased blood glucose (Healy et al., 2007) and increased risks of developing MetS (Bertrais 
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et al., 2005). Sedentary time has also been implicated in elevated risk of cardiovascular events and 
all-cause mortality (Stamatakis, Hamer, & Dunstan, 2011). Moreover, it appears that the 
comparatively short periods of leisure time physical activity do not mitigate the detrimental effects 
of longer daily periods of sedentary behaviour (Healy, Matthews, Dunstan, Winkler, & Owen, 2011; 
Stamatakis, Hamer, & Dunstan, 2011; Wijndaele et al., 2009). 
Long periods of daily sitting, as that occuring in occupations such as professional, administrative 
or clerical office work, may be harmful to health. Recommendations to meet 150 minutes a week of 
moderate level activity (Haskell et al., 2007) may be ineffective in reversing the detrimental changes 
seen as a result of prolonged sedentary behaviour and there have been calls for a new focus to be 
placed on reducing daily sedentary time (Dunstan, Howard, Healy, & Owen, 2012). To date, there 
have been few intervention programmes aimed at specifically reducing levels of occupational sitting 
(Chau et al., 2010), but with further evidence emerging about the harm caused by prolonged 
sedentary behaviour, there is a pressing need to investigate ways to reduce the long term effects on 
the health of the population. The majority of attempts to reduce sitting time exist in the domain of 
leisure-time physical activity and any interventions intended to reduce occupational sitting are 
limited in number. 
This study is a preliminary investigation into the use of a standing workstation to reduce 
occupational sedentary behaviour. Through the measurement of waist circumference, BMI, systolic 
and diastolic blood pressure, blood glucose, triglycerides and HDL cholesterol, data were used to 
explore relationships between the use of a standing workstation and potential changes in markers 
of MetS. Additionally, by using inclinometry to objectively record standing and sitting duration, 
changes to daily occupational standing and sitting times were identified. 
1.2. Format of this thesis 
This work is presented in a chapter based thesis format. Chapter 1 provides background 
information on MetS and the effects of prolonged sedentary behaviour on the markers of metabolic 
health. Chapter 2 is a literature review examining the effects and acceptability of sit-stand and 
standing workstations on metabolic health. Chapter 3 describes study methods, design, data 
collection and analysis. Chapter 4 presents the results for each participant. Chapter 5 concludes 
with a discussion examining the results of the study, and includes limitations and recommendations 
for future research. 
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1.3. Rationale for study design 
There is a distinct lack of research on occupationally driven sedentary behaviour patterns in the 
workplace. There is also very limited research on interventions to reduce occupational sedentary 
behaviour in predominantly sitting-based workplaces, as experienced by professional or 
administrative workers. While strong evidence indicates that excess sitting is associated with a 
range of negative health effects (Dunstan et al., 2010; Matthews et al., 2012; Stamatakis et al., 
2011; Van Gaal, Mertens, & De Block, 2006), well controlled clinical trial data is required to test an 
occupational intervention on sitting on a large scale.  The most appropriate research design to 
investigate causal relationships between the use of standing workstations and changes in MetS 
markers would be a randomised controlled clinical trial. Designs of this type require the sample to 
be randomised to an intervention or control group, where participants are blinded to the application 
of intervention or placebo (Akobeng, 2005). While a study of this nature would provide greater 
robustness of data with reduced bias, there is little current scientific evidence of this novel 
intervention to justify the resource requirements, high financial and time costs associated with the 
design and execution of a randomised controlled trial to investigate standing workstations and 
health effects. By using a single-case design study, indications about the relationships may be 
identified that enable better quality hypothesis generation for subsequent clinical trial 
investigations. 
The use of single-case design studies allows for researchers to experiment with novel 
interventions to gain insight into possible relationships between the intervention and dependent 
variables, by using an N-of-1 design where the same outcome variables are repeatedly measured 
through a number of phases (Kratochwill et al., 2010; Logan, Hickman, Harris, & Heriza, 2008). 
Participants act as their own control through a baseline phase before introduction of the 
intervention and in many cases a withdrawal phase is included. 
Interpretation of single-case design studies is performed through visual analysis, focusing on 
clinical significance rather than statistical significance (Gross, 2008; Kratochwill et al., 2010). Each 
participant’s results are presented individually with phase trend, variability and level within and 
across phases, so that the interpreter of the single-case study can generate sound hypotheses about 
the relationship between intervention and dependent variables. 
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1.4. Metabolic syndrome 
1.4.1. Definition 
Metabolic Syndrome is a cluster of clinical signs that appear to occur more commonly together 
than might be expected by chance. The identification of the components is attributed to Reaven 
(1988) when he identified a group of systemic changes associated with increased risk of CVD; 
namely hypertension, impaired glucose tolerance, hyperinsulinaemia, increased plasma 
triglycerides and decreased (HDL cholesterol). Although Reaven (2006) is a harsh critic of the 
concept of MetS, his work has become the corner-stone for the definition of MetS. The collection of 
these metabolic markers has been strongly implicated in the development of CVD and the 
development of T2DM in non-diabetic individuals (Alberti et al., 2006; Grundy, Brewer, Cleeman, 
Smith, & Lenfant, 2004; Roger et al., 2011). 
The classification of MetS has been debated in recent years, with particular attention paid to 
whether it is insulin resistance or obesity that best explains the increased risk. Several classifications 
have been defined and even though many are now dated, they are still regularly used. The World 
Health Organisation criteria (referred to as WHO criteria) (1999), National Cholesterol Education 
Program—Third Adult Treatment Panel criteria (referred to as ATPIII criteria) (2001) and the 
European Group for the Study of Insulin Resistance criteria (referred to as EGIR criteria) (Balkau & 
Charles, 1999) have each released their own definitions of MetS along with criticisms of the criteria 
used by other groups. Whilst each group agrees that a collection of clinical signs is present, which 
predisposes people to CVD and T2DM, they place different emphasis on the relevance, importance 
and specific cut-off levels for the markers known under the current understanding of MetS; insulin 
resistance, dyslipidaemia, central obesity and hypertension. At the heart of the argument is the fact 
that MetS is still poorly understood and that finding the balance between an accurate definition 
using epidemiological studies and a description that translates into easily administered office-based 
tests, is difficult. The euglycaemic clamp technique used in the WHO criteria, for example, is the 
‘gold-standard’ for assessing insulin resistance and requires maintained glucose infusion for a 
minimum of 120 minutes with blood samples taken every 10 minutes (Kim, 2009). While this 
method is very accurate, it is highly impractical for wide-scale epidemiological studies or clinical 
settings, where a simple tool is needed to aid in diagnosis and treatment (Eckel, Grundy, & Zimmet, 
2005). 
In 2006, the International Diabetes Federation (International Diabetes Federation, 2006) held a 
consensus workshop (Alberti et al., 2006) in order to produce a new definition of MetS and  
standardise the measurement for clinical practice and to improve the methodological quality of 
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international epidemiological studies. More recently, a joint interim statement has been released by 
the International Diabetes Federation, World Health Organisation, The National Heart, Blood and 
Lung Institute, American Heart Association and the International Association for the Study of 
Obesity (Alberti et al., 2009) in order to move closer to a unified definition for diagnosis (Table 
1.4.1). Importantly, each of these criteria for diagnosis represents a ‘crude’ measurement for a 
complicated spectrum of an inability to maintain homeostasis. For example, a component of MetS 
diagnosis is based on a combination of high triglycerides and low levels of HDL cholesterol; 
however, this is only one small component of a spectrum of changes. The impact of insulin 
resistance and central obesity also produces changes in unmeasured markers such as a proliferation 
of triglyceride rich LDL cholesterol, as well as a decrease in LDL size which significantly increases 
risk of CVD (Reaven, 2006). These changes are important but also make for a more complicated 
diagnosis. Instead, MetS uses selected signposts to represent a large, complicated systemic change. 
Finally, the diagnostic criteria for MetS will constantly evolve as we understand more about the 
metabolic changes in the body. As new tools are developed to diagnose and understand the impact 
of the ‘cardiometabolic risk’ (Després & Lemieux, 2006), MetS may no longer be defined as a simple 
grouping of commonly occurring clinical signs. 
 
 
Table 1.4.1 – The Metabolic Syndrome Joint Interim Statement. 
Table adapted from (Alberti et al., 2009) 
Metabolic Syndrome is diagnosed as the presence of any three of the following: 
Central obesity  Elevated waist circumference (country specific) 
Raised triglycerides ≥1.7 mmol/l (150 mg/dl)  
 or 
Specific treatment for this lipid abnormality 
Reduced HDL cholesterol < 1.0 mmol/l (40 mg/dl) in males 
< 1.3 mmol/l (50 mg/dl) in females 
 or 
Specific treatment for this lipid abnormality 
Raised blood pressure Systolic: ≥130 mmHg 
 and/or 
Diastolic: ≥85 mmHg 
 or 
Specific treatment of previously diagnosed hypertension 
Raised fasting glucose Fasting plasma glucose ≥5.6 mmol/l (100 mg/dl) 
 or 
Specific treatment for elevated glucose 
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1.4.2. Clinical outcomes and burden of disease 
The presence of MetS increases the risks of developing CVD, T2DM and stroke, as well as an 
increased risk of all-cause mortality (Isomaa et al., 2001; Mottillo et al., 2010). A limitation inherent 
in quantifying risk lies in the multiple definitions of MetS. Nonetheless, there is strong evidence to 
show that those with MetS have increased risk of developing CVD (ATPIII random effects estimate = 
1.65, 95% CI = 1.38-1.99, WHO fixed effects estimate = 1.37, 95% CI = 1.09-1.74) and an increased 
risk for all-cause mortality (ATPIII random effects estimate = 1.27, 95% CI = 0.98 – 1.5, WHO fixed 
effects estimate = 1.93, 95% CI = 1.39-2.67) when compared to those without MetS (E. Ford, 2005). 
Cardiovascular disease accounted for an estimated 17.5 million deaths worldwide in 2012; 31% of 
all global deaths (World Health Organization, 2015a). The global deaths for diabetes were 1.5 
million people in 2014; 9% of all adult deaths (World Health Organization, 2015b). In New Zealand, 
cerebrovascular disease and ischaemic heart disease – both components of CVD – accounted for 
8,199 deaths in 2011; 27% of all deaths. Diabetes accounted for 835 deaths in the same period; 2.8% 
of all deaths (Ministry of Health, 2014a). Combined, both of these diseases account for 1 in 3 deaths 
in New Zealand. 
The financial burden of MetS outcomes are unclear due to a lack of recent published research. 
Although now dated, Scott, White, and Scott (1993) estimated the tangible costs of coronary heart 
disease, such as costs of hospital stays, ambulance and pharmaceuticals, to be $179 million for the 
year of 1992. Intangible costs, such as changes in quality of life or loss of employment, were 
estimated to be up to $246 million in the same period (Scott et al., 1993). Tangible costs for 
ischaemic stroke in 1992 were $140 million (Scott & Scott, 1994). For 2008 the costs for T2DM were 
$600 million, an increase of $350 million in just 7 years (Diabetes New Zealand & 
PricewaterhouseCoopers, 2008). While these figures are outdated, they allow an understanding of 
the escalating costs due to increased prevalence of MetS. Adjusting these figures for inflation 
(http://www.rbnz.govt.nz/monetary_policy/inflation_calculator/), the costs of care for stroke, CVD 
and T2DM may be more than $1 billion dollars per annum in 2015. 
More recent estimates of the financial burden of ischaemic heart disease suggest that the costs 
associated with hospital care, general practitioner costs and pharmaceuticals is an estimated $287 
million per annum (National Health Committee, 2014). Estimates from the Auckland District Health 
Board  estimate the national costs for coronary heart disease to be between $307 and $467 million 
per annum, with the national costs for stroke to be between $100 and $150 million per year 
(Auckland District Health Board, 2011). These cost estimates are for hospital visits and 
pharmaceutical intervention and do not take into account the financial costs of loss of quality of life 
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or loss of employment. While the true financial burden of MetS is difficult to specify due to lack of 
data, the total cost to the country is likely to be substantial. 
The burden of disease is commonly measured in “disability-adjusted life years”. The measure is a 
combination of “years of life lost” – the number of years lost from early death – and “years lived 
with disability” – the number of years of lost health while living with ill-health. In 2006 in New 
Zealand, 955,000 years of healthy life were lost; 51% as a result of death and 49% as a result of non-
fatal outcomes. Coronary heart disease was the number one cause of loss of health, accounting for 
89,159 disability-adjusted life years (9.3% of total). Health loss from stroke, ranked third, accounted 
for 37,688 disability-adjusted life years (3.9% of total) and diabetes, ranked fifth, accounted for 
28,800 years lost (3%) due to death or disability (Ministry of Health, 2013b). Each year of life lost 
represents considerable financial costs, as well as personal loss for family members and ongoing 
implications for those caring for members of the community living with disability.  
1.4.3. Prevalence 
In the United States, it is estimated that the syndrome affects 24% of the adult population (E. S. 
Ford, Giles, & Dietz, 2002) using the ATPIII (2001) criteria. Although now dated, Gentles et al. (2007) 
provides data that gives an indication of prevalence in the New Zealand context. Gentles et al. 
(2007) estimated that in the Auckland population, MetS was present in 32% of Maori adults, 39% of 
Pacific Island adults and 16% of European adults aged 35-74. The criteria for MetS diagnosis was not 
reported by Gentles. Simmons and Thompson (2004) also assessed the prevalence of MetS within 
the Auckland population. Their study of 1,562 non-diabetic South Auckland residents aged >40 
years used the ATPIII (2001) criteria to assess the population at risk. They found that among Maori 
and Pacific Island peoples, 80% of the sample had at least 2 components of MetS and 50% were 
able to be diagnosed under the ATPIII criteria. In European peoples, 50% of females and 25% of 
males had at least 2 components and MetS diagnosis could be made in 15% of females and 25% of 
males. 
It is difficult to apply the Auckland MetS prevalence findings to the entire country due to the 
diversity of cultural, physical activity and dietary differences across New Zealand regions. For 
example, the 2011-2013 Health Survey (Ministry of Health, 2013a) showed that the rate of adequate 
physical activity (>150 mins/week) ranged from 49.5% in Northland to 36.8% of adults in Counties 
Manukau. Dietary variations may also create disproportionate rates of MetS throughout the 
country. In the Nelson-Marlborough district the prevalence of adults meeting vegetable intake 
guidelines (89.0%) and fruit intake guidelines (63.7%) is greatly different to that of Waitemata 
(55.7% and 57.8% respectively) (Ministry of Health, 2013a). Cultural and ethnic diversity, particularly 
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in relation to physical activity, can also influence the prevalence of MetS. Obesity and lack of 
physical activity are both more prevalent in Pacific Island and Maori peoples (Ministry of Health, 
2014b). The increased prevalence of obesity and decreased levels of physical activity may lead to a 
higher rates of MetS in Auckland, where 30% of Pacific Island peoples and 25% of Maori peoples 
live, compared to 9% Pacific Island and 10% of Maori peoples living in Wellington (Statistics New 
Zealand and Ministry of Pacific Island Affairs, 2010; Statistics New Zealand, 2014). Whilst Auckland 
MetS statistics cannot translate directly to the entire country, a broader understanding might be 
reached by examining health statistics for individual markers of MetS from the New Zealand Health 
Survey 2013/14. 
The 2013/14 New Zealand Health Survey (Ministry of Health, 2014b) revealed that of the 13,000 
adults sampled (aged 15 years and over), 16% were receiving pharmaceutical treatment for 
hypertension and 11% were receiving treatment for high cholesterol. Other findings showed that 
2% of the sample had experienced a stroke, 30% were obese – body mass index (BMI) >30 km/m2 – 
and 6% had been diagnosed with a form of diabetes; although the authors do not state whether this 
is limited to Type I, Type II or includes those in a prediabetic state (Ministry of Health, 2014b). Whilst 
these numbers represent a substantial proportion of the population, it is highly likely that many of 
these individuals will experience a combination of the markers of MetS which, while relevant to 
MetS, are not of sufficient clinical importance to be included in the survey results. For example, a 
non-smoking male aged 55-64 with systolic blood pressure of 160 mmHg and 
hypercholesterolaemia expressed in a cholesterol:HDL cholesterol ratio of >8, is classified as having 
a ‘moderate 10-15%’ 5 year risk according to The New Zealand Primary Care Handbook (New 
Zealand Guidelines Group, 2012). In this same individual, MetS criteria (Alberti et al., 2009) would 
be met for hypertension and it would be very likely that criteria be met for HDL cholesterol. 
However, in this scenario, the Handbook suggests lifestyle-based changes with no pharmaceutical 
intervention, therefore missing classification for hypertension in the Health Survey results. 
One third of the New Zealand population is obese (Ministry of Health, 2014b) and therefore meets 
at least one criteria for MetS diagnosis (Alberti et al., 2009). Given that obesity is a strong predictor 
for hypertension, hypertriglyceridaemia, CVD and diabetes, it may be that an epidemiological study 
in New Zealand could discover that the incidence of MetS is significant. By comparing the 
prevalence of MetS in an Australian study by Cameron, Shaw, and Zimmet (2004) – 9.5% for males 
and 17.2% for females  – and extrapolating to include New Zealand obesity and Auckland MetS 
statistics, it is possible that the prevalence of MetS across the entire New Zealand population may 
be between 20% and 30%. To be confident of the exact statistics it is important that further 
objective data be obtained through studies focused on the broader New Zealand context. 
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1.4.4. Features of metabolic syndrome 
The factors involved in the classification of MetS are closely linked - influencing each other 
collectively via mechanisms that are not currently well understood. As research focuses, a 
developing picture emerges of a ‘dangerous quartet’ of metabolic changes. 
Conventional thinking suggests that long periods of sedentary behaviour (Hamilton, Hamilton, & 
Zderic, 2007) and excess energy intake (Després & Lemieux, 2006) are producing an obese 
population. Normally, caloric surplus is stored as triglycerides and cholesterol esthers in 
subcutaneous adipocytes for use in caloric-deficient periods. In some individuals, such as those with 
insulin resistance or those who lack subcutaneous adipocytes, triglycerides can be stored in skeletal 
muscle, as well as in viscera around the liver, heart, pancreas and other organs (Després & Lemieux, 
2006). This hallmark appearance of central obesity, as a result of an ectopic fat distribution of organ 
triglyceride and visceral adipose tissue surplus, has more serious negative health effects than the 
cosmetic aesthetics of modern society demand. Based on the evidence base, it is considered that 
factors predisposing people to visceral obesity can include age, lack of physical activity, genetics, 
ethnicity, sex steroids and oestrogen deficiency at menopause. These predisposing factors can 
result in disproportionate fat storage and visceral-obesity even in non-obese individuals (Carr & 
Brunzell, 2004). 
Adipocytes are not only efficient in the storage of excess fats, but they are also important 
endocrine-producing cells. Of the many adipocytokines produced to help maintain lipid 
homeostasis, several products of adipocytes have been identified to influence metabolic health. 
Pro-inflammatory marker release of interleukin-6 and tumour necrosis factor-α from adipocytes is 
higher in obese patients than non-obese patients, particularly when visceral obesity is present. 
Unlike subcutaneous adipocytes, these pro-inflammatory markers released from visceral 
adipocytes drain directly into the portal vein and towards the liver, where they result in an increased 
production of C-reactive protein (Fontana, Eagon, Trujillo, Scherer, & Klein, 2007). Collectively C-
reactive protein, interleukin-6 and tumour necrosis factor-α are circulated, promoting a system-
wide inflammatory response which is a classic marker for metabolic disturbance. 
Conversely, of the many serum adipocytokines released by subcutaneous fat storage in healthy 
people, adiponectin is seen to provide positive benefits to metabolic health. In human and mouse 
models, normal levels of adiponectin found in non-obese people causally decreases the 
development of insulin resistance, as well as decreases the risk of atherosclerosis, improving lipid 
oxidisation and vasodilation function throughout the body (Després & Lemieux, 2006; Ryo et al., 
2004). In patients with central obesity, adiponectin levels are decreased in both the peripheral veins 
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and the portal vein (Fontana et al., 2007; Ryo et al., 2004; Yamauchi et al., 2001). This lowered level 
of adiponectin may have an important influence on the development of MetS as a result of obesity, 
as the natural protective mechanisms mediated by adiponectin are lost, leading to higher risks of 
T2DM in obese patients. 
Systemic inflammatory response may be more influential on metabolic health than first expected, 
as explained by Odegaard and Chawla (2013) . Nutrients are commonly stored in the liver, white 
adipose tissue and muscles, where these ‘metabolic professionals’ are able to quickly release energy 
in periods of demand. Dietary overload leads to cellular break-down and release of nutrients into 
the extracellular matrix. It is believed that the inflammatory signalling from cellular death of storage 
cells, such as adipose tissue, inhibits local and systemic insulin signalling as well as recruiting 
macrophages. It has been seen in obesity-induced adipocyte storage that the macrophage 
population increases from approximately 10% of adipose tissue normally, to 50% of adipose tissue 
in obese subjects, further amplifying the insulin-suppressing effects created by a system-wide 
inflammatory response (Odegaard & Chawla, 2013). 
Several mechanisms may lead to hypertriglyceridaemia, although these processes are currently 
poorly understood. In cases of central obesity or primary insulin resistance, the visceral adipose 
tissue has a high non-esterified fatty acid turnover and subsequent release into the portal vein. Non-
esterified fatty acid overload of an insulin-resistant liver results in higher hepatic synthesis of 
triglycerides into the system and subsequently the development of hypertriglyceridaemia (Grundy, 
1999). Furthermore, it is thought that this fatty acid overload at the liver leads to an increased 
production of apolipoprotein B. Apolipoprotein B is the structural binder of chylomicrons, very-low 
density lipoprotein and LDL cholesterol; normally referred to in the lay press as ‘bad cholesterol’. 
Apolipoprotein B is an atherogenic lipoprotein and contributes directly to atherosclerosis. It is likely 
that the increased production of triglyceride-rich very-low lipoprotein cholesterol and small-particle 
LDL cholesterol result in atherogenesis as they easily pass into the arterial wall where proteoglycan 
binding and macrophage response occurs (Carr & Brunzell, 2004; Van Gaal et al., 2006). 
Ongoing debate exists regarding the central feature of MetS and whether insulin resistance or 
central obesity provides the strongest correlation between all other features. Alternatively, it has 
been argued that all traits are largely independent and that diagnosis of MetS should abandon 
hierarchy and place equal emphasis on all features (Anderson et al., 2001). Insulin resistance 
increases central adipocytes and skeletal triglyceride storage (Després & Lemieux, 2006). Hepatic 
insulin resistance, in combination with central adiposity, leads to increased free fatty acids release 
and hypertriglyceridaemia (Grundy, 1998). This cycle is complete when excess-free fatty acid 
circulation promotes the further development of insulin resistance, as well as further promoting the 
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development of hypertriglyceridaemia by down-regulating the function of lipoprotein lipase (Eckel 
et al., 2005). Finally, the decreased levels of adiponectin seen in those with central obesity also 
promote greater insulin resistance, further increasing central adiposity.  
As insulin resistance is a strong predictor for raised cholesterol, triglycerides, blood pressure and 
increased risk for CVD (Alexander, Landsman, & Teutsch, 2000; Zavaroni et al., 1987), it is likely that 
without intervention the presence of insulin resistance contributes to and is influenced by the other 
markers of MetS in a close grouping that are all predisposed and aggravated by one another. 
Finally, blood pressure may too be influenced by insulin resistance, hypertriglyceridaemia and 
central obesity. The vasodilatory effects of insulin are lost in resistant individuals when blood 
vessels stop dilating in response to insulin secretion and instead abundant free fatty acids create 
vasoconstriction (Kuroda et al., 1999). Paired with upregulated sodium retention as a result of high 
plasma insulin levels (Eckel et al., 2005), increased sympathetic drive and membrane transport 
interference (DeFronzo & Ferrannini, 1991), insulin resistance increases blood pressure. This high 
blood pressure, combined with high levels of atherogenic lipoproteins found in MetS and a system-
wide inflammatory response (Odegaard & Chawla, 2013), eventually leads to the development of 
hypertension and atherosclerotic plaque formation (Grundy, 1999). 
1.4.5. The metabolic effects of sitting down 
In recent years, research has discovered a correlation between sedentary behaviour, such as time 
spent sitting or lying down and the risk factors for MetS. Outcomes of long periods of sedentary 
behaviour include increased BMI (Mummery et al., 2005), increased waist circumference (Wijndaele 
et al., 2009) and increased blood glucose (Healy et al., 2007). Beyond the measure of individual 
components, the diagnosis of MetS in adults who spent more time sitting down is higher than those 
who are more active (Bertrais et al., 2005; Wijndaele et al., 2009). This link between sedentary 
behaviour and metabolic health outcomes is compelling and suggests that, in addition to existing 
interventions such as medication, lifestyle or dietary changes, we might find benefit in changing the 
amount of time we spend sitting down. 
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1.5. Sedentary behaviour 
1.5.1. Defining sedentary behaviour 
Sedentary behaviour is distinct from other forms of activity, such as light intensity physical activity 
and moderate or vigorous intensity physical activity. Sedentary behaviour, from the Latin word 
sedere – to sit, is defined as a waking behaviour with a very low-energy expenditure <1.5 metabolic 
equivalents, that occurs when laying down or sitting still (Ainsworth et al., 2000; Sedentary 
Behaviour Research Network, 2012). Time spent sitting does not fall into the continuum of physical 
activity intensity. Instead, it appears that sedentary behaviour has unique and independent effects 
on many health outcomes (Hardy et al., 2012). 
A large volume of data are available as to the benefits of moderate to vigorous physical activity 
and very precise recommendations have been made by authorities such as the American College of 
Sports Medicine and the American Heart Association about the exercise requirements for adults 
(Haskell et al., 2007). The importance and influence of sedentary behaviour and light intensity 
physical activity; however, have only recently been recognised. Assessing the sedentary behaviour 
patterns in adults is less obvious and what research that does exist on the subject is often focused 
on adolescents. This focus on adolescent behaviour is perhaps as a result of technological 
developments in screen-based entertainment, such as computer games, which compete with 
physical activity (Biddle, 2004) and results in research being rarely focused on sedentary adults. 
Sedentary behaviour is classified as activity that requires 1 metabolic equivalent, that is, the 
energy expended by sitting still (Ainsworth et al., 2000). Light intensity physical activity is 
considered to be that which expends <3.0 metabolic equivalents and might occur whilst doing such 
activities as walking slowly around the office or standing. Moderate physical activity is defined as 
that between 3.0 and 6.0 metabolic equivalents and would occur whilst doing such activities as 
walking briskly, housework or playing golf. Vigorous intensity activity is that which expends >6.0 
metabolic equivalents, such as jogging, swimming or performing heavy manual labour. For those 
who work in offices, such as professionals (law, accounting or finance) or clerical/administration 
staff, it is likely that a large part of the day is comprised of sitting; sitting whilst commuting, sitting 
whilst at work, sitting for lunch or sitting in front of the television in the evening. 
In a comprehensive review by Rhodes, Mark and Temmel (2012), the impacts of sedentary 
behaviour was correlated against common biopsychosocial traits. They examined 109 peer-
reviewed articles that investigated the correlates of sedentary behaviour in non-clinical adults, 
independent of physical behaviour. Their review found that television-based sedentary behaviour 
increases with age and is also higher in unemployed people. Computer-based sedentary behaviour 
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was higher in young adults rather than middle-aged or older adults, as well as those with higher 
levels of education. Further observations by Rhodes explain that television viewing (but not 
computer use) appears to be linked to decreased physical activity, increased depressive symptoms 
and lower psychological well-being. 
1.5.2. The “sitting epidemic” and occupational sedentariness 
A comprehensive large-scale study (n = 49,493, age 18-65) by Bauman et al. (2011) used the 
responses from the International Physical Activity Questionnaire of 20 countries to create a 
snapshot of the descriptive epidemiology of sitting. They state the mean sitting time for all 
countries was 5.8 h/day with no differences found between males and females. Adults aged 19 to 39 
years were likely to spend more time sitting per day than adults >40 years old and those with >13 
years of education were more likely to sit than those with <13 years education.  
Bauman et al. (2011) reveal that in New Zealand (n = 1447), the median sitting time was 4 h/day. 
By quintile, 21.5% of those sampled sat <3 h/day, 28.7% sat between 3 h/day and 4 h/day, 21.9% sat 
between 4 h/day and 6 h/day, 14.3% sat between 6 h/day and 9 h/day and 13.6% of the sample sat 
for >9 h/day. Similar to international findings, no significant differences existed between males and 
females for median sitting time. Significantly greater median sitting time was observed for those 
with >13 years education (5/h day) than for those with <13 years education (4 h/day) and 
significantly greater sitting time was observed for those aged 18 to 39 (5 h/day) than for those aged 
>40 years (4 h/day).  
Less data exist for sitting time by specific periods of the day. Half of the New Zealand adult 
population sit for at least 4 h/day, about the same percentage of the population who are considered 
to be physically inactive, i.e. those who fail to meet the minimum of 30 minutes a day of moderate-
intensity physical activity (Ministry of Health, 2014b). However, it is not clear how much of this total 
sedentary time is comprised of occupational sitting, leisure time sitting or time spent sitting whilst 
commuting to work. 
In a cross-sectional survey of Dutch workers (n = 7720) between 2000 and 2005 (Jans, Proper, & 
Hildebrandt, 2007), sedentary time was examined by period of the day and also by industry. On 
average, Dutch workers spent 7 hours each day sitting – comprising of 30% (2 hours) at work, 5% (21 
minutes) travelling to and from work and 66% (4.7 hours) in ‘other’ sedentary time during the day 
and evening. Sitting time was higher for full-time workers than part-time workers and the highest 
levels of sedentary behaviour inside and outside of the workplace were found in professional and 
clerical occupations.  
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In a cross-sectional Australian study by Mummery et al. (2005) the self-reported occupational 
sedentary behaviour of 1579 full-time workers in Queensland found that the average occupational 
sitting time was >3 h/day and in 25% of the sample, the average occupational sitting time was >6 
h/day. It was found that sitting time was higher in both sexes for professional (4.1 h/day) and ‘white-
collar’ workers (3.5 h/day), than for ‘blue-collar’ workers (2.3 h/day) (Mummery et al., 2005). 
It is therefore plausable to make broad comparisons between Australia and New Zealand due to 
close historical, cultural, economic and political similarities. In New Zealand in 2014, there were 2.4 
million people in employed work, with roughly 60% of these working >35 h/week (Statistics New 
Zealand, 2015). Professional and administrative roles – managers, professionals, clerical and 
administrative workers – account for 52% of the current New Zealand workforce. If 60% of those 
workers are full-time, working 35 hours or more a week, then it is plausible that a third of New 
Zealand adults in full-time employment spend an average of 3.5 to 4.1 h/day sitting in the workplace 
alone. 
1.5.3. Measuring sedentary behaviour 
Measurement of sedentary time and physical behaviour is complicated and a number of 
mechanisms exist to do so – each with their own advantages and disadvantages. Hardy et al. (2012) 
describe the different options available and their benefits and limitations (see Table 1.5.1). 
When assessing sedentary behaviour on a large scale with a number of participants, subjective 
questionnaires may be used to assess physical activity ‘yesterday’ or ‘last Tuesday’ or ‘in a typical 
week’. Whilst this method is simple for participants and allows for scaling, it is also unreliable due to 
its subjective nature. For example, the New Zealand Physical Activity Questionnaire and the 
International Physical Activity Questionnaire both show an overestimation of physical activity levels 
when compared to objective accelerometer data (Boon, Hamlin, Steel, & Ross, 2010). Additionally, 
participants may be forgetful if the period of time is too long or answers may be biased as the 
participant responds with what they feel should be the norm or the socially acceptable answer. 
Observation methods to identify sedentary behaviour may be done using video or with a data 
collector present in the room. Both these methods allow the researcher to gain useful information 
of the sedentary position of the participant as well as context to the activity, e.g. ‘participant is 
sitting at a workstation using a computer’. This method, whilst good for short periods of time (such 
as 24 hours), is time consuming for the data collector and may be considered too invasive for many 
participants. This method may also influence the behaviour of participants resulting in inaccurate 
data. Described as the ‘Hawthorne effect’, observation of behaviour can result in a change of 
participant behaviour (McCarney et al., 2007). 
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Physical activity and sedentary behaviour information may also be captured using digital data 
devices, such as an accelerometer, inclinometer or screen monitoring software. All three can 
provide highly accurate data, but lack the context of the activity and behaviours. Accelerometers 
capture robust data regarding physical activity, which are then analysed and movement counts can 
describe energy expenditure, metabolic equivalents and other physical activity information using 
established cut-points such as the popular Freedson (1998) or Puyau (2002) criteria. Inclinometers 
use angle measurement in x, y and z axes to determine the position of a participant’s thigh or waist 
and count time spent standing, walking or sitting/lying. Both of these measurement methods 
require the participant to wear a small data capture device, which may be uncomfortable to 
participants over a long period of time. Devices are also prone to failure and need to be monitored 
carefully for battery life and correct operation. 
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1.6. Sedentary behaviour and health outcomes 
1.6.1. Psychological health 
More time spent in sedentary behaviour is associated with higher levels of psychological disorders, 
such as anxiety, depression or distress (Kilpatrick, Sanderson, Blizzard, Teale, & Venn, 2013; 
Sanchez-Villegas et al., 2008; Teychenne, Ball, & Salmon, 2008). In a study of 10,381 Spanish 
graduates, Sanchez-Villegas et al. (2008) found that those with >42 h/week of sedentary time were 
31% more likely to develop a psychological disorder than those who spent <10 h/week in sedentary 
behaviour.  
In the workplace, sedentary behaviour has implications for psychological distress. A Tasmanian 
survey of 3,367 government employees found that compared to those occupationally sitting for <3 
Table 1.5.1 – Limitations and considerations associated with measuring sedentary behaviour. 
Modified from Hardy et al. (2012). 
 Accelerometers Inclinometers Screen Monitoring Observation Self-Report 
Cost High financial High financial High financial High financial and 
time 
Low financial, 
moderate time 
Data 
captured 
Small to large Small to large Small Small Small to large  
Method Objective 
Prospective/Current 
Objective. 
Prospective/Current 
Objective. 
Prospective/Current 
Objective. 
Prospective/Current 
Subjective. 
Retrospective 
Data 
captured 
Counts body 
movement 
(accelerations) in 
real time; 
algorithms used to 
indicate level of 
activity 
Time spent in 
different postures, 
including sitting, in 
real time. Number 
of sit-to-stand 
transitions 
Total time spent 
viewing electronic 
screen for each 
individual 
Time spent in 
different 
posture/intensity, 
including 
sitting/sedentary 
Average frequency 
and/or duration of 
overall sitting or of 
specific sedentary 
behavior 
Data entry 
and data 
reduction 
complexity 
High – data 
downloaded to 
computer and 
reduced using 
specialised software 
High – data 
downloaded to 
computer and 
reduced using 
specialised software 
Low – data recorded 
by device 
Low – manual data 
entry table 
Low – manual data 
entry table 
Sources of 
error 
Unable to 
distinguish between 
standing still and 
sitting. No standard 
protocol for data 
management or 
reduction 
Unable to 
distinguish between 
lying and sitting. No 
contextual 
information (e.g., 
type of behavior) 
Assumption that 
participant is 
sedentary while 
engaged in ‘screen 
time’ 
Potential for 
participant 
reactivity. Data 
collection method 
can be considered 
invasive 
Poor respondent 
memory and/or 
motivation. 
Susceptibility to 
socially desirable 
responses. 
Incomplete 
entries/missing data 
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h/day, men who sat at work for >6 h/day were more prone to moderate psychological distress 
(prevalence ratio = 1.90, 95 CI = 1.22 to 2.95) and women who sat for >6 h/day were more prone to 
moderate (prevalence ratio = 1.25, 95% CI = 1.05 to 1.49) and high levels (prevalence ratio = 1.76, 
95CI = 1.25 to 2.47) of distress. These results were found to be independent and unaffected by levels 
of leisure time physical activity or by levels of self-reported work-related stress (Kilpatrick et al., 
2013). Interestingly, in a study of 1,995 adults using self-reported sedentary behaviour and objective 
pedometer data, long periods of physical activity in the workplace for women (>10 h/week) were 
associated with twice the level of depression compared to those who were completely sedentary in 
the workplace (McKercher et al., 2009). This research did not suggest occupational types, but it is 
unlikely that office workers are exposed to such long periods of occupational physical activity. What 
it may represent; however, is that influence on psychological distress of physical activity and 
sedentary behaviour is not necessarily on a continuous scale and may instead be unique. 
With all of the previously discussed research findings, it is important to note that no causal 
relationship is implied between sedentary behaviour and psychological state due to the cross-
sectional nature of the research. It may be that altered psychological states drive sedentary 
behaviour or that sedentary behaviour in conjunction with anxiety or depressive predisposition only 
aggravates the symptoms. Additionally, it may be that while physical activity ameliorates negative 
psychological health such as depression (McKercher et al., 2009; Teychenne et al., 2008), sedentary 
behaviour is might be independently harmful on existing psychological conditions (Kilpatrick et al., 
2013). 
1.6.2. Cancer risk 
In a study of 488,720 participants, assessing the impact of sedentary behaviour on colon and rectal 
cancer, Howard et al. (2008) found that overall sedentary time was associated with an increase in 
colon cancer risks. Men who spent >9 h/day in sedentary screen time experienced an increase in the 
risk of colon cancer (risk ratio = 1.61, 95% CI = 1.14 to 2.27) compared to men who sat for <3 h/day. 
The effects of sedentary behaviour are also present for other cancers. An increased risk (hazard 
ratio = 1.55, 95% CI = 1.08 to 2.22) for ovarian cancer was seen in women who spent > 6 h/day in 
sedentary behaviour compared to <3 h/day (Patel, Rodriguez, Pavluck, Thun, & Calle, 2006). Similar 
effects can be seen on the risks for endometrial cancer rates. In a study of 70,000 women, it was 
found that sitting for 5-6 h/day increased the risk of endometrial cancer (risk ratio = 1.29, 95% CI = 
1.02 to 1.63), with higher increases in risk for those sitting >7 h/day (risk ratio = 1.23, 95% CI = 0.96 to 
1.57) when compared to women who sat <3 h/day (Gierach et al., 2009). Importantly, these risks 
were independent of all vigorous activity, suggesting that any direct influence of sedentary 
behaviour on cancer may occur regardless of physical activity levels. 
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1.6.3. Prolonged sitting and metabolic health 
In one of the first published studies examining sedentary behaviour, it was recognised that excess 
sitting time was harmful to health and well-being. Morris and Crawford  (1958) concluded that those 
individuals employed in largely sedentary jobs (such as bus drivers or telephonists), had twice the 
rate of CVD as their standing counterparts - bus conductors and mail deliverers. Nearly 50 years 
later there is irrefutable evidence that sedentary behaviour is associated with an increased risk of 
T2DM, CVD, cardiovascular mortality and all-cause mortality (Dunstan et al., 2010; Matthews et al., 
2012; Stamatakis et al., 2011; Van Gaal et al., 2006). 
The beneficial effects of physical activity have been well documented and there is irrefutable 
evidence to demonstrate that regular physical activity can help to prevent myriad diseases including 
CVD, diabetes and hypertension (Warburton, Nicol, & Bredin, 2006). In recent years, a growing 
pattern is emerging in research studies suggesting that the effects of sedentary behaviour are 
unique and independent of the levels of physical activity and that reducing sedentary behaviour 
levels may be as important as increasing daily physical activity levels (Healy, Dunstan, et al., 2008). 
Sedentary behaviour clearly influences the markers of metabolic health. For example, Mummery 
(2005) found that men who spent >6 h/day in occupational sitting were twice as likely (odds ratio =  
1.92, 95% CI = 1.17 to 3.17) to have a BMI >25 kg/m² than those who sat <45min/day. Sedentary 
behaviour was also found to be associated with increased waist circumference and decreased HDL 
cholesterol in men and increased waist circumference and blood pressure in women, independent 
of leisure time physical activity (Wijndaele et al., 2009). Research has also demonstrated that blood 
glucose status is linked with sedentary behaviour. As a subset of the AusDiab study, Healey et al. 
(2007) used accelerometers to measure physical behaviour against 2-hour plasma glucose tests. It 
was found that sedentary behaviour was positively associated with higher 2-h plasma glucose levels 
and that light intensity physical activity and moderate to vigorous physical activity were associated 
with lower 2-h plasma glucose levels. 
The effects of sedentary behaviour are not limited to individual markers of MetS, but also to 
increased prevalence of actual diagnosis. In a French study of 3,834 men and women, Bertrais et al. 
(2005) saw that after adjusting for self-reported physical activity there was an increased risk for 
MetS (ATPIII criteria) for men (odds ratio =  1.39, 95% CI = 0.97 to 1.99) and women (odds ratio =  
3.3, 95% CI = 2.04 to 5.34) for >3 h/day sedentary behaviour compared to <2 h/day. 
The effects of sedentary behaviour are also implicated in changes to overall health. In a widely 
cited study, Stamatakis et al. (2011) compared the results of 4,512 respondents from the 2003 
Scottish Health Survey with the Scottish Information Division Database (of hospital visits and 
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deaths) up until 2007. By examining sitting time (measured by self-reported screen time) against 
cardiovascular events and all-cause mortality, they concluded that those who spent >4 h/day sitting 
had increased risk of cardiovascular events (hazard ratio = 2.3, 95% CI = 1.33 to 3.96) and increased 
risk of mortality from all-causes (hazard ratio = 1.52, 95% CI = 1.06 to 2.16) when compared to those 
who sat <2 h/day. When adjusted for physical activity, it was seen that these risks were not 
attenuated, suggesting that moderate and vigorous intensity physical activity levels did not impact 
on the risks. Mediating variables for cardiovascular events were also examined and it was found that 
25% of events could be explained by C-reactive protein, BMI and HDL cholesterol. Interestingly, it 
was found that C-reactive protein levels were 3-fold higher for those who spent >4 h/day sitting 
compared with those who spent <2 h/day sitting (Stamatakis et al., 2011). This suggests that 
inflammatory and metabolic pathways may explain a link between sedentary behaviour and 
metabolic illness. 
Changes to C-reactive protein were also seen in a study of 4,757 American adults using objective 
accelerometer data. After adjusting for physical activity, total sedentary behaviour was associated 
with deleterious changes to waist circumference, HDL cholesterol, C-reactive protein, triglycerides 
and insulin. Furthermore, independent of physical exercise, breaks in sedentary time were positively 
associated with improvements to waist circumference, C-reactive protein and fasting glucose 
(Healy et al., 2011). 
A study by Wijndaele et al. (2009) used a continuous scoring model for MetS, in place of binary 
assessment, to assess the influence of questionnaire-reported sedentary behaviour (n=992, age 18-
75) on the markers of this syndrome. As with studies previously mentioned, they concluded that 
MetS risk was positively associated with sedentary behaviour in both men and women, independent 
of leisure time physical activity. By using the same continuous MetS scoring model, Healy et al. 
(2008) used objective accelerometer data to analyse relationships between metabolic health and 
sedentary behaviour, light intensity physical activity and moderate to vigorous physical activity in 
169 participants (age 30-87) of the AusDiab study. They found that on average, participants spent 
>90% of accelerometer wear time in sedentary behaviour or light intensity physical activity and that 
sedentary behaviour was positively associated with increased MetS risk and increased waist 
circumference, independent of moderate to vigorous physical activity. 
The strong body of evidence suggests that the more time spent in sedentary activity, the greater 
the negative effects on metabolic health. However, it is worth noting that research conducted by 
Healy et al. (2008) showed that, regardless of total daily sedentary time, the total number of breaks 
in sedentary activity was associated with a significant decrease in the risks of MetS such as low HDL 
cholesterol, increased waist circumference, increased and 2-h plasma glucose levels, even after 
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adjusting for intensity of breaks and moderate to vigorous physical activity. This finding alone does 
not implicitly suggest that total daily occupational sitting time should be left unconstrained as long 
as sitters stand up every 15 minutes. Instead, it could be argued that a multifactorial approach 
should be taken, where total sitting time is reduced through workstation alternatives and 
recommendations are put in place to break up prolonged periods of sitting where employees are 
required to do so. 
Important learnings must be taken from this research. Firstly, sedentary behaviour is positively 
correlated with deleterious changes in both specific markers of MetS, as well as the health 
outcomes of MetS such as diabetes and CVD (Bertrais et al., 2005; Healy et al., 2007; Van Gaal et al., 
2006). Secondly, many of these negative effects on metabolic health are still present even after 
adjusting for levels of physical activity in both subjectively and objectively measured studies (Healy 
et al., 2011; Stamatakis et al., 2011; Wijndaele et al., 2009). Being active for 150 minutes per week is 
not negating the harm of time spent sitting. Instead, these data make a clear case that a focus must 
be made to decrease total sedentary time in order to assist with the high levels of poor metabolic 
health. 
1.6.4. Mechanisms of harm in sedentary behaviour 
Sedentary behaviour has unique effects on the risks for disease that are independent of the 
beneficial effects of physical activity (Dunstan et al., 2005; E. S. Ford, Kohl, Mokdad, & Ajani, 2005). 
Physical activity may not be a scale from sedentary to vigorous intensity; instead the mechanisms 
involved in sedentary behaviour are likely to be entirely different from the mechanisms involved in 
physical activity. Even in people who do not actively exercise (roughly half of the New Zealand 
population), a large amount of light intensity physical activity is achieved throughout the day by 
activities such as standing whilst cooking, running to catch the bus or walking to collect the printing 
in the workplace. Since light intensity physical activity is inversely related to sedentary time, as well 
as the risk factors for metabolic disease (Healy et al., 2007), it should be recognised that as well as 
extolling the virtues of moderate to vigorous physical activity, we must also acknowledge the 
benefits of light intensity physical activity and fight the growing societal trend towards sedentary 
behaviour. 
Sitting, as an activity, requires less energy expenditure than standing, walking or moving. In 
assessing the energy expenditure between standing up and sitting down, Reiff, Marlatt and Dengel 
(2012) collected and measured expired gasses from young adults (n=10, mean age 22.8 years old) 
using sitting workstations and then standing workstations. Although the results were small, 
significant increases were detected for caloric expenditure whilst standing, compared with sitting. 
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From their data, participants would have increased energy expenditure by 20 kcal/hour. Whilst this 
number is a fifth of the energy in that of a medium-sized banana, it is perhaps representative of 
wider physiological changes that occur whilst in light intensity physical activity. 
Standing recruits a large number of muscle contractions in the biggest muscle groups in the body. 
This increase of muscle fibre recruitment during postural muscle demand when standing may 
produce beneficial cellular processes that ameliorate the markers for disease. One such mechanism 
is the involvement of lipoprotein lipase (Hamilton et al., 2007). In rat models, hind-leg unloading 
showed a substantially lower level of lipoprotein lipase activity in slow-twitch and fast-twitch 
muscles compared to standing periods with hind-leg loading. Additionally, triglyceride uptake into 
skeletal muscles was also substantially higher in standing rats than in inactive rats. Lipoprotein 
lipase down-regulation from sedentary behaviour leads to a reduced ability of muscles to clear 
chylomicrons from the blood, leaving the plasma rich in triglycerides. 
Limited evidence suggests that skeletal muscle GLUT4 receptors may be influenced by increases 
in sedentary behaviour. Following bodyweight-supported treadmill training, 9 participants with 
incomplete spinal cord injuries showed improvements in muscle GLUT4 function (Phillips et al., 
2004). The glucose transporter is normally upregulated by physical exercise; however, following low 
weight loading the researchers saw a 126% increase in skeletal muscle GLUT4 content as well as 
improved oral glucose tolerance tests (Phillips et al., 2004). By increasing light intensity physical 
activity, there is potential for increased GLUT4 function, particularly in the large postural leg 
muscles, therefore aiding glucose regulation. Importantly, as GLUT4 function is upregulated 
through skeletal muscle contraction independent of insulin action, the up-regulation of the glucose 
transporter may aid in metabolic regulation even in insulin resistant-individuals. 
1.7. Conclusion 
Metabolic Syndrome is a cluster of clinical signs occurring commonly together that increase risks 
of predisposition to CVD, T2DM, stroke and other preventable diseases. Although continuing 
international discussion occurs over the definition of MetS, the current knowledge defines it as a 
homeostatic imbalance, leading to central obesity, elevated blood pressure, raised blood glucose, 
triglycerides and decreased HDL cholesterol. Whilst it is difficult to accurately comprehend the 
impact in New Zealand, the syndrome may occur in 20 to 30% of the adult population. 
Sedentary behaviour involves physical activity of low energy expenditure, such as sitting or lying 
down. In New Zealand, 50% of the population sit for more than 4 hours/day - enough to increase 
morbidity. Sitting is more prevalent in professional or administrative jobs and in young adults with 
higher levels of education. As increasing use of technology tends to decrease the level of physical 
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activity, these young and educated individuals are likely to experience the greatest negative 
influence on health in the next decade. 
Metabolic syndrome appears to be modified by sedentary behaviour. The result of an excess of 
sedentary behaviour can be seen in the increased risks of obesity, lowered HDL cholesterol, 
increased blood pressure and blood glucose. Furthermore, sedentary behaviour increases the risk of 
CVD as well as all-cause mortality. Irrefutable evidence suggests that the physiology of sedentary 
behaviour is different to that of physical activity and that these risks are not affected by levels of 
physical activity outside of sedentary periods. 
The mechanisms by which sedentary behaviour positively changes risk of MetS are poorly 
understood. By decreasing sedentary behaviour and increasing light intensity physical activity (such 
as standing or walking), we might attenuate the harmful effects of sitting down. In addition, where 
occupational sitting is mandated for any length of time, it has been recommended that bouts of 
prolonged sitting are broken up with regular periods of standing, potentially providing further 
beneficial influences to the markers of MetS. While this appears to be a sensible suggestion, further 
objective data is needed to confirm. By combining workstation modification as well as behavioural 
changes, the rising trend towards sedentary behaviour and metabolic imbalance may be effectively 
addressed. 
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Chapter 2. Changing behaviour through standing workstations. A review of the 
literature 
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2.1. Introduction 
Decreasing occupational sedentary behaviour, such as that prevalent in the office environment, can 
occur using a number of different interventions. By utilising an office-wide approach including positive 
role-modelling and a supportive social environment, changes can be made to sedentary behaviour 
patterns by promoting active meeting breaks (Yancey et al., 2004) or encouraging ‘active office’ 
environments (Dunstan et al., 2012) where increased activity is achieved through behaviour change. 
Previous research undertaken on the adoption of the ’10,000 step challenge’ has demonstrated that the 
use of pedometers to increase awareness of physical activity helps to promote the reduction of sedentary 
behaviour and helps employees meet current daily physical activity recommendations (Le Masurier, 
Sidman, & Corbin, 2003). These types of interventions, however, succeed only to reduce sedentary 
behaviour when workers are away from their desks and therefore arguably provide health benefits at the 
cost of occupational productivity. Extrapolating further, it is fair to assume that a large majority of 
companies would be unwilling to implement company-wide adoption of physical activity interventions 
that have the potential to negatively impact the company’s bottom line. Reducing occupational sitting 
must be effective at decreasing the time spent in sedentary behaviour with minimal negative effects or 
even positive effects on employee performance and output.  
This review looked for original research articles through primary database search or via secondary 
channels such as reference sections of existing papers. Database searches were performed on Google 
Scholar, Science Direct, Ebscohost and PubMed. Specifically, research articles that investigated the use of 
standing or sit-stand workstations in the workplace and that measured physiological and anthropometric 
changes were closely examined. Changes included those that might influence metabolic health, such as 
energy expenditure, changes to sedentary behaviour and changes to the markers of Metabolic Syndrome. 
In addition, articles that examined the user acceptability of sit0stand workstations were examined in order 
to provide context in to the feasibility of this thesis. Seven articles were found matching these criteria 
(Table 2.4.1). Additionally, this review attempts to provide a brief contextual understanding of both the 
broader psychological and physiological impacts of sit-stand or standing workstations - in particular the 
influences on musculoskeletal symptoms, productivity or psychological changes. 
 
2.2. Sedentary behaviour and metabolic risk modification 
In many ways, the relative dearth of experimental studies examining the effects of sit-stand and standing 
workstations demonstrates the novelty surrounding the concept of reducing sitting time, especially in the 
workplace. It should be recognised that sedentary behaviour reduction does exist in several forms for 
occupational settings; however, this review will not examine the effects of ‘active-workstations’, such as 
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treadmill or cycle workstations, as it could be argued that this would not only replace sitting time with 
light intensity physical activity such as standing, but also introduce moderate intensity activity, which is 
not a focus during this study. 
Four studies examined the energy expenditure differences between sitting down and standing up in the 
workplace. Evidence was found that standing up for short periods of time significantly increased energy 
expenditure when compared to sitting down. Rieff et al. (2012) discovered that the use of a standing  
workstation (1.36 ± 0.20 kcal/min) for 45 minutes resulted in an increased caloric demand of 20.4 kcal/hour 
when compared to sitting down (1.02 ± 0.22 kcal/min). Similar results were seen by Thorp et al. (2013) over 
an 8-hour period of standing with an increase of 11.2 kcal/hour (2873 ± 458 kcal vs 2784 ± 403 kcal, t = 8h) 
and by Buckley, Mellor, Morris, and Joseph (2014) with a gained energy expenditure of 50 kcal/hour over a 
3-hour standing period (487 ± 174 kcal vs 313 ± 139 kcal, t =  120min). No significant differences were 
observed by Speck and Schmitz (2011) for kcal or metabolic equivalent expenditure in their 7-minute 
intervention. Whilst the results seen by Rieff, Thorp, and Buckley could be considered small, over an 8-
hour working day of full-time standing this could arguably equate to 89 kcal to 163 kcal of additional 
energy expenditure, which is the equivalent caloric expenditure of roughly 5.4 kg of weight gained per 
year from over-eating by 120 kcal/day (Katan & Ludwig, 2010). 
If reducing workplace sedentary behaviour through lifestyle modification is to be achieved, then it is 
important that interventions are able to decrease the daily sitting time. Studies investigating the effect of 
time spent in sedentary positions were examined and although the evidence is somewhat limited, the data 
do suggest that the use of a sit-stand or standing workstation is effective at decreasing daily sitting time. 
Alkhajah et al. (2012) provided participants with a dedicated sit-stand solution that attached to their 
current workstations. Using objective accelerometer data, they found that within 1 week, sitting time had 
reduced by 143 minutes per day compared to a control sitting group. Encouragingly this same decrease 
was maintained when remeasured after 3 months of standing. Neuhaus, Healy, Dunstan, Owen, and Eakin 
(2014) similarly observed a reduction in sitting time across two of their intervention groups when 
compared to a sitting-only control group. In a group receiving a sit-stand workstation alongside a ‘multi-
component’ education program, total daily sitting time was reduced by 89 minutes compared to the 
control group. In a group receiving a sit-stand workstation only, a reduction of total daily sitting time of 33 
minutes was experienced compared to the control group.  
It is worth noting that both of the aforementioned studies by Alkhajah and by Neuhaus utilised 
dedicated standing workstations for their participants, which could arguably be considered a vital 
mechanism in achieving participatory compliance. Gilson Suppini, Ryde, Brown and Brown (2012) on the 
other hand, tested the use of standing ‘hot-desks’ in the workplace, whereby participants could 
temporarily relocate from their existing sitting desk and were encouraged to use the standing ‘hot desk’ 
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workstations for any amount of time. The use of the standing workstations ranged dramatically from 0 
h/day to 9 h/day; however, no significant change in sedentary time across the entire group was observed. 
The perceived barriers presented by ‘hot-desks’ may be too great to see effective uptake. For example, the 
process of logging off one computer and on to another each day (or multiple times during the day) 
involves a greater amount of effort than having one dedicated work station. Similarly, workstation 
availability can become difficult and motivation hampered, if several staff members have set up for the 
day on a standing workstation and there are only a limited number available. It can therefore be argued 
that the establishment of dedicated standing workstations in offices is advantageous to the reduction of 
sedentary behaviour by providing participants with the opportunity to sit or stand at their own will, 
whenever they wish to do so. 
Only two of the reviewed studies examined the effects on the metabolic markers of health through the 
use of standing up workstation alternatives. As well as measuring changes in sedentary time, Alkhajah et 
al. (2012) also measured BMI, waist and hip circumferences, body fat composition as well as fasting total 
cholesterol, HDL cholesterol, triglycerides and glucose across  a 3-month standing intervention program. 
An average increase in HDL cholesterol of 0.26 mmol/L was detected in the intervention group, with no 
other significant differences observed. Buckley, Mellor, Morris, and Joseph (2014) assessed the post-lunch 
blood glucose levels of individuals after 185 minutes of sitting and 185 minutes of standing. They found 
that the postprandial blood glucose levels after standing were 43% lower than after sitting. These results 
provide encouraging evidence to suggest that replacing occupational sitting time with light intensity 
physical activity may produce positive metabolic health benefits by reducing the markers for MetS. 
 
2.3. Acceptability, usability and performance effects 
Regardless of the reported health benefits of behaviour modification experienced with sit-stand or 
standing workstations, if the workstation is seen as a detractor from normal productivity or comfort levels 
it will likely be rejected by both employers and employees as a viable workplace intervention. In a study by 
Alkhajah et al. (2012) using small ‘add-on’ sit-stand workstations that elevated only the keyboard and 
mouse, participants reported greatly enjoying the experience and preferred to stand whilst working. 
However, participants found the design of the desk to be a detractor as it lacked space to rest their hands. 
Introducing a standing workstation to a work environment must address practical concerns like these to 
achieve acceptance and buy-in. 
Work-related musculoskeletal disorders represent a third of all occupational disorders in the United 
States, Japan and all Nordic countries, as prolonged periods of sitting can produce back, neck and arm 
pain as a result of prolonged static postures (Punnett & Wegman, 2004). For decades, we have seen large-
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scale investment into the innovation of workplace ergonomics and chairs, which can cost upwards of 
several hundreds of dollars per product. For standing workstations to be a viable company investment, 
their use must ideally produce the same or better levels of comfort and potentially a decrease of 
musculoskeletal symptoms. Pronk, Katz, Lowry, and Payfer (2012) saw decreased upper back and neck 
pain in participants following the introduction of standing workstations in the workplace and 
improvements were negated following the removal of the workstation at the end of the intervention. 
Whilst a decrease in musculoskeletal symptoms was similarly shown by Robertson, Ciriello, and Garabet 
(2013) in their research on standing workstations, their findings also highlighted the importance of training 
and education in the overall efficacy of the intervention. Participants with ergonomic education embraced 
standing over sitting and reported lower discomfort levels and experienced increased standing times 
compared to a control group who had the opportunity to stand but had received no training.  
Sitting for long periods of time increases feelings of moderate to high psychological distress in both men 
and women (Kilpatrick et al., 2013). Pronk, Katz, Lowry, and Payfer (2012) included psychological 
assessment in their standing study and discovered that following 4 weeks of standing, participants’ mood-
states improved for fatigue, vigour, tension, confusion and depression. The benefits of the standing 
workstation were further highlighted when participants reported that these improvements in mood-states 
returned to baseline levels following the removal of their standing workstations.  
No effect on speech or typing performance was noted between standing and sitting workstations (Beers, 
Roemmich, Epstein, & Horvath, 2008; Cox et al., 2011; Ebara et al., 2008), indicating that a standing 
workstation intervention is unlikely to negatively impact these requirements in the workplace. Enhanced 
performance effects also appear to be sustained over long periods of time even after the initial ‘novelty’ of 
a standing workstation has diminished. In their standing study, Pronk, Katz, Lowry, and Payfer (2012) 
found that participants had greater feelings of focus and productivity whilst standing and that work 
performance, reinforcing the suggestion that focus could potentially improve as a result of using a 
standing workstation (Ebara et al., 2008; Grunseit, Chau, van der Ploeg, & Bauman, 2012). 
 
2.4. Conclusion 
The installation of standing workstations in the workplace appears to reduce the amount of sitting time 
and increase the level of standing time, which is still evident after prolonged periods of time. Reducing 
prolonged sedentary behaviour through the increase of light intensity physical activity may be important 
in reducing the risk factors associated with MetS leading to CVD, T2DM and stroke. This may be due to the 
fact that the use of standing workstations not only increases hourly caloric energy expenditure, but also 
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affects biochemical markers, as seen in the decrease in postprandial blood glucose concentrations in 
standers compared to sitters. 
In order for sit-stand or standing workstations to be embraced as a viable and attractive solution to 
reducing sedentary behaviour in the workplace, they must be both practical and accessible to their users. 
The availability and type of standing workstations is important to encourage uptake and good user 
experience as well. The use of shared ‘hot-desk’ standing workstations is a detractor for various reasons 
including the motivational barriers of constant relocation and resource scarcity. The size and design of the 
desk is also important as users should be able to have space to spread out, rest their arms comfortably and 
stack paperwork at the same level as the keyboard and mouse. 
Overall, there appears to be little to no negative influences on workplace performance, psychological 
mood or musculoskeletal discomfort when using a standing up desk. For users to spend longer periods of 
time standing up, it is crucial that they feel no increase in fatigue, pain or discomfort. Equally, for 
employers to implement and encourage the use of standing workstations, it is important that no decrease 
in work output and performance is experienced by their employees.  
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Table 2.4.1 – Sit-stand workstation interventions on sedentary behaviour and metabolic health 
Study Sample Design Intervention Age Environment Outcome measures Findings 
Alkhajah et al. 
(2012) 
n=18 
(intervention 
n=8) 
Two-arm quasi-
experiment. 1 week 
baseline, 3 month 
intervention 
Sit-stand workstation (add-
on, dedicated) 
20-
65 
University 
campus (staff 
and students) 
Average sit/stand/step. BMI. 
Fat free mass. Fat mass. Waist 
and hip circumference. Fasting 
HDL cholesterol, triglycerides, 
glucose. Self reported 
outcomes. 
2h decrease in sitting time at 1 week 
and 3 months. Increase in HDL 
cholesterol compared to observation 
group (average 0.26 mmol/l) 
Buckley, Mellor, 
Morris, and Joseph 
(2014) 
n=10 Single group, repeat 
measures. 1 day 
baseline, 1 day 
intervention 
Standing workstation 
(replacement, dedicated). 
185 minutes  
22-
59 
Office staff Capillary glucose - continuous 
measurement. Overnight 
fasting glucose. Waist-band 
accelerometer. Chest-strap 
heart rate monitor 
Postprandial glycaemic excursion 
decreased by 43% (p=0.022) after 
185mins standing. Energy 
expenditure 0.83kcal/min (p=0.028) 
greater in standers. No change in 
overnight fasting glucose. 
Gilson, Suppini, 
Ryde, Brown, and 
Brown (2012) 
n=11 Single group, repeat 
measures. 1 week 
baseline, 1 week 
intervention 
Standing desk (hot desk, 
voluntary) 
46.9 
(9.8) 
Office staff Activity - 
sedentary/light/moderate. Arm 
band accelerometer. 
Standing desk use between 0 and 
9h35m. No overall significant change 
to behaviour. 
Neuhaus, Healy, 
Dunstan, Owen, 
and Eakin (2014) 
n=44 
(intervention 
n=16 and 
n=14) 
Three-arm quasi-
randomised controlled 
trial. 7 day baseline, 3 
month intervention 
Sit-stand workstation, Sit-
stand workstation with 
multicomponent education 
20-
65 
University 
campus (staff) 
Accelerometer - time spent in 
activity 
Workplace daily sitting time reduced 
by 89mins in multicomponent and 33 
mins in workstation only group 
compared to control 
Reiff et al. (2012) n=20 Randomised, 
controlled, crossover 
Standing desk (temporary). 
45 minutes 
22.8 
± 1.9 
Laboratory 
setting 
Energy expenditure - oxygen 
consumed (VO2), carbon 
dioxide produced (VCO2), and 
minute ventilation (VE). 
Producing kcal/min 
Significant increase in all participants 
for VO2, VCO2, VE and Kcal/min. 
Speck and Schmitz 
(2011) 
n=13 Single group, 15 
minute baseline, 7 
minute intervention 
Chair, exercise ball, 
standing workstation 
44.2 
(8.5) 
Laboratory 
setting 
Energy expenditure - O2 
consumption, kcal/min, METs 
No significant differences 
Thorp et al. (2013) n=8 Single group, repeat 
measures. 1 day 
baseline, 1 day 
intervention 
Sit-stand workstation. 8 
hours - intermittent bouts 
30 minutes sitting/standing 
48.2 
(7.9) 
  Energy expenditure - kJ/day Significant increase for kJ/day 
expenditure (89.2 kJ/day) 
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3.1. Study design 
The study was designed as a single AB Baseline-Intervention model (Kratochwill et al., 2010) with no 
repeat phases and was conducted between April and October 2014. The lack of withdrawal and repeat 
intervention phases are multifactorial, due to the longitudinal nature, logistical complications of furniture 
supply and ethical implications. The format of the results section follows the guidelines described for 
single-case designs (Kratochwill et al., 2010) and adaptations to the standard AB model will be described 
and explained where necessitated. 
3.1.1. Phases of experiment 
The study was composed of three periods over a total of 21 weeks; 1) baseline (5 weeks), 2) phase-in (3 
weeks) and 3) intervention (13 weeks) (see timeline overview in Figure 3.1.1). Participants were scheduled 
to undergo anthropomorphic and biochemistry sampling every four weeks as well as data export from the 
Actigraph.  
The baseline was comprised of a 5 week period. Participants experienced day to day work-life without 
any sedentary activity intervention. Anthropometry and biochemistry data collected at the start and 
completion of this phase with inclinometry data collected at the completion. 
The phase-in period commenced in week 6 for a total of 3 weeks. A sit-stand or dedicated standing 
workstation was installed and participants commenced the phase-in period by transitioning to full-time 
standing. No data collection points during this phase. 
The intervention phase commenced in week 9 and ran for 13 weeks, except where participants withdrew. 
Participants were instructed to be “mostly” standing by this time with sitting breaks taken at their own 
discretion. Data collection points occurred at the start of the intervention phase and occurred repeatedly 
at 4 week intervals until cessation. 
 
3.2. Participant recruitment 
Six participants were recruited from the general public using a custom website (Appendix A) as well as 
coverage from a local newspaper and a national news website (http://www.stuff.co.nz/auckland/local-
news/auckland-city-harbour-news/9917147/Benefits-of-working-standing-up-studied). Initial eligibility 
Figure 3.1.1 – Overview of study timeline. 
Shaded cells indicate data collection points. 
 
 
Baseline Phase-in Intervention
Week 1 Week 6 Week 9 Week 21
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was screened using an online questionnaire (Appendix B) and potential participants were then mailed an 
information sheet (Appendix C) and a consent form (Appendix D) for consideration prior to meeting the 
primary researcher. Safety information for blood tests (labtests.co.nz/images/Practise_Manual/4.1.10-
Safety-Information-For-Patients.pdf) and instructions for fasting tests 
(labtests.co.nz/images/Practise_Manual/4.1.4-Fasting-tests.pdf) were also provided to participants. Due 
to the placement of new furniture, participants were required to gain consent from their employers to be 
included in the study. All participants gave written informed consent and the study was approved by the 
Unitec Research Ethics Committee (UREC 2013-1029) (Appendix E). 
3.2.1. Inclusion criteria 
Participants were required to be aged between 25 and 40 years with a self-reported height and weight 
that resulted in a BMI of between 25 and 30 kg/m2. A minimum self-estimated daily occupational sitting 
time of 5 hours was a requirement with a low expectance of time away from work over the 5 month study 
period. All participants were required to be registered with a general practitioner in case of the need for 
referral due to elevated risk of metabolic events. 
3.2.2. Exclusion criteria 
Potential participants were excluded if they had been previously diagnosed with CVD, any form of 
diabetes or MetS. Any history of angina or stroke resulted in ineligibility, as well as smoking or current 
medication that may alter blood pressure, blood glucose, triglycerides or cholesterol concentration or be 
currently taking weight loss medication or other weight loss programme.  
3.2.3. Lifestyle variables 
During the study, participants were asked to avoid changes in diet and leisure activity to maintain what 
they consider to be typical of their six-month average. It was considered outside of the scope of this study 
to monitor food intake or physical exercise outside of the inclinometer wear-time over the period of 
participation. As such, participants were not required to maintain a log of any food intake or physical 
activity. The study was purposefully conducted outside of the New Zealand summer holiday period of 
December to January to avoid seasonal changes in physical activity associated with leisure activities. 
3.3. Equipment 
Following a baseline period, participants were supplied with one of two workstation configurations on 
the basis of availability: a fixed-height workstation and stool, that could be adjusted to suit participant 
height at installation, of custom design and manufacture (AUT University, Auckland, NZ); or a ‘Sit to stand 
electric Desk’ (Linak New Zealand Ltd, Auckland, NZ) to be used with the participant’s existing chair. The 
allocated workstations were installed by the researcher to temporarily replace the participant’s current 
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seated workstation. The fixed height workstations and stools were adjusted according to the participant’s 
height upon installation and participants were encouraged to seek assistance from the researcher if they 
perceived the need for further minor adjustment. 
As required for ethical approval of the study, participants were given opportunity to purchase their 
workstation or a suitable similar workstation, at the conclusion of the intervention period. Workstations 
were removed at the end of the study where participants did not wish to purchase the supplied furniture. 
Participants were supplied with an Actigraph GTX3+ or a wGTX3+ (Actigraph, Pensacola, FL) for the 
duration of the study to be worn during work hours. The Actigraph was fastened mid-way on the lateral 
thigh (left or right at participant preference) using a custom made elastic strap and a plastic clip for easy 
removal. The thigh was selected following pilot tests, which showed greatest accuracy in a variety of 
sitting and standing postures or when standing with legs crossed over, such as when leaning on furniture. 
A power-adapter was supplied to charge the device as well as an information sheet for recognising faults 
(Appendix F). Participants were not asked to record a log of Actigraph wear time. 
3.4. Training and support 
At the beginning of the phase-in period participants were provided with brief verbal instructions on the 
use of a standing workstation and recommended posture. A printed information sheet was supplied to 
participants at the start of the phase-in period to assist with the transition from sitting to regular standing 
(Appendix G). This included simple mobility exercises intended to ease discomfort and prevent venous 
pooling from prolonged standing. Additional information or advice was provided as necessary where 
participants had specific questions about comfort. To allow a progression to comfortable standing, 
recommendations about daily standing bouts were provided with an end-goal of reducing daily 
occupational sedentary time by 80%, by increasing standing by 5 to 7 hours per working-day (Table 3.4.1). 
No requirements were made as to the duration or frequency of standing bouts, only total work-day 
standing time. 
 
  
Table 3.4.1 – Phase-in period transition to standing recommendations 
Week 1 3 days with a total of 1 hour standing each day 
2 days with a total of 2 hours standing each day 
Week 2 3 days with a total of 3 hours standing each day 
2 days with a total of 4 hours standing each day 
Week 3 3 days with a total of 5 hours standing each day 
2 days with a total of 6 hours standing each day 
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3.5. Anthropomorphic, biochemical and physical activity variables 
Although the recommendation for 5 data points is suggested as a minimum in single-case design studies, 
this study was limited to 2 in the baseline and 4 in the intervention phase due to financial and resource 
limitations. 
3.5.1. Anthropometry 
Participant height was measured at the commencement of the trial using a 90° angle against a wall and a 
retractable fibreglass tape measure (NCD Medical Limited, County Dublin, IRL). Weight, waist 
circumference and blood pressure were measured every four weeks in an appointment at the participant’s 
workplace. Due to the professional office environment, participants were not required to remove any 
clothing although it was recommended that lightweight clothing was worn for each appointment.  
All measurements during the study were performed by a single trained researcher to reduce inter-rater 
error. Weight was taken using digital scales (WW185A, Conair Australia Pty Ltd., Belrose, NSW) following 
the removal of heavy clothing, shoes and belt. Waist circumference was measured over a single layer of 
clothing (shirt or underwear) using a retractable fibreglass tape measure (NCD Medical Limited, County 
Dublin, IRL) to the nearest 1cm at the narrowest point between the lowest ribs and the iliac crest (Alberti 
et al., 2006). Blood pressure was be measured at the left brachial artery while seated, using a 
sphygmomanometer (Riester Ri-San Palm, Rudolf Riester GmbH, Bruckstr, DE) and stethoscope 
(Littmann Classic II SE stethoscope, 3M, St. Paul, MN) by averaging 3 measurements with 60s intervals 
(Wijndaele et al., 2009).  
3.5.2. Biochemistry sampling 
A total of 6 fasting blood tests were required at 4 week intervals. Biochemistry sampling was performed 
by phlebotomists at Labtests Ltd (Auckland, NZ) collection centres. Participants were permitted to attend 
a collection centre of their choice when required. Automated biochemical sample analysis was performed 
by commercial laboratory (Labtests Ltd) using Siemens Advia 2400 (Siemens Healthcare Diagnostics Inc., 
Tarrytown, NY). Tests performed were Glucose Hexokinase_3 (GLUH_c) (Siemens Healthcare Diagnostics, 
2010), Direct HDL Cholesterol (D-HDL) (Siemens Healthcare Diagnostics, 2008), and Triglycerides (TRIG) 
(Siemens Healthcare Diagnostics, 2009). 
3.5.3. Inclinometry 
Actigraph raw data was downloaded from the device at the participant’s location every 4 weeks using 
proprietary software (Actilife 6.8.2, Actigraph, Pensacola, FL). In the case of loss of charge no new data 
was collected until the device was recharged and recalibrated at the next collection appointment.  
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3.6. Statistical Analysis 
3.6.1. Anthropometry and biochemistry 
Data were analysed using linear regression in Graphpad Prism 6.0 (GraphPad Software, Inc, La Jolla, CA) 
for the overall study period. Effect sizes (Cohen’s d) were calculated using the means of the first two 
measurements in the baseline period and the means of the last three measurements (or less due to 
missing data) in the intervention period. Effect sizes are interpreted using Cohen’s (1988) standard 
interpretation: 0-0.2 ‘small’, 0.3-0.5 ‘medium’, 0.6-0.8 ‘large’, >0.8 ‘very large’. 
Due to the visual nature of data interpretation for single-case design studies (Kratochwill et al., 2010), 
data points and best-fit trend lines were plotted for each participant. Any changes to dependent variables 
were considered meaningful if they exceeded the known upper and lower limits of the standard error of 
measurement; that is, change between the mean must exceed twice the known technical error of measure 
or biological variation, whichever is larger. 
Technical error of measurement for blood glucose concentration was 1.8% (2 mmol/L), 1.3% (4.9 
mmol/L) and 1.5% (16.7 mmol/L) (Siemens Healthcare Diagnostics, 2010). Technical error for blood 
triglyceride concentration was 2.5% (1.32 mmol/L) and 1.5% (2.36 mmol/L) (Siemens Healthcare 
Diagnostics, 2009). Technical error for blood HDL cholesterol concentration was 2.2% (0.91 mmol/L), 2.1% 
(1.39 mmol/L) and 2.5% (1.95 mmol/L) (Siemens Healthcare Diagnostics, 2008).  
Biological variation for waist circumference was 1.31 cm (World Health Organization, 2011), 10% and 
12.6% for systolic and diastolic blood pressure respectively (Mancia et al., 1983). Biochemistry biological 
variation was 4.8% for blood glucose (Widjaja et al., 1999), 21% triglycerides (Widjaja et al., 1999) and 
12.4% for HDL cholesterol (Demacker, Schade, Jansen, & Van  ’t Laar, 1982). Note that these figures are 
likely a combination of the technical error of measurement and true biological variation. No technical error 
of measurement statistics or biological variation were available for BMI. 
3.6.2. Inclinometry 
Actigraph device output was captured using Actilife 6.8.2 at a 60s epoch. Data were validated to include 
only wear time. Actilife output data was calculated into total weekday standing time, stepping time and 
sitting time (mins) using a custom spreadsheet (Excel, Microsoft Corporation, Redmond, WA) for 
weekdays of the hours between 8.00 am and 6.00 pm. Activity periods shorter than 60s or continuous 
periods longer than 120 min were excluded to reduce jitter and non-wear periods respectively. Daily 
inclinometry data was normalised by activity to a 600 min period using the following method: 
𝑡𝑜𝑡𝑎𝑙 𝑑𝑎𝑖𝑙𝑦 𝑛𝑜𝑚𝑎𝑙𝑖𝑠𝑒𝑑 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (𝑚𝑖𝑛𝑠) = (
𝑡𝑜𝑡𝑎𝑙 𝑑𝑎𝑖𝑙𝑦 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑡𝑖𝑚𝑒 (𝑚𝑖𝑛𝑠)
𝑡𝑜𝑡𝑎𝑙 𝑑𝑎𝑖𝑙𝑦 𝑤𝑒𝑎𝑟 𝑡𝑖𝑚𝑒 (𝑚𝑖𝑛𝑠)
) × 600 (mins) 
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Linear regression was analysed for overall standing, stepping and sitting for each period of the study; 
baseline, phase-in and intervention. Effect size (Cohen’s d) was calculated using the means of the entire 
baseline period and the means of the entire intervention period. 
3.7. Risk reduction and test results 
In case of elevated risk detected during biochemistry sampling or anthropomorphic measures, a letter 
was sent to the participant’s GP in accordance with the risk levels indicated in the New Zealand Primary 
Care Handbook 2012 (New Zealand Guidelines Group, 2012) as shown in Table 3.7.1.  
 
Table 3.7.1 - High risk criteria for participant referral.  
Adapted from New Zealand Guidelines Group. (2012). New Zealand Primary Care Handbook 2012. Wellington. 
Reprinted with permission. 
Cardiovascular Risk – participant presents with any of the following 
Obesity BMI >30kg/m2 or waist circumference >100cm in males or >90cm in 
females 
Blood Pressure BP ≥ 160/95 mmHg 
Cholesterol Total Cholesterol ≥8mmol/L or TC:HDL ratio ≥7 
 
Diabetic Risk – participant presents with 2 or more of the following 
Lipids ≥1.7mmol/L, TC ≥4mmol/L 
Blood Pressure BP ≥140/80 mmHg 
Fasting Glucose ≥6.1 mmol/L 
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Chapter 4. Results 
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4.1. Participant recruitment 
A total of 43 registrations of interest were received with an average age of 35 (SD = 10.05) years. 
Initial screening excluded 29 people due to age, BMI, history of disease or planned absence of work. 
Information packs and consent forms were supplied and a further 6 people withdrew their interest. 
Of the remaining 8 people, 6 were recruited in order of acceptance of place. A flow diagram of the 
study is shown in Figure 4.1.1 and demographics of participants can be seen in Table 4.1.1. 
 
  
Figure 4.1.1 – Flow diagram of participant recruitment and enrolment 
 
29 Ineligible
6 Withdrew
Participant D withdrew week 12
Participant F withdrew week 18
4 Completed full intervention
6 Completed phase-in
6 Completed baseline
6 Selected in order of registration
14 Information and consent forms 
supplied
43 Registrations of interest
Table 4.1.1 – Participant demographics at start of study. 
I.D. Age (years)  BMI (kg/m²) Gender 
Participant A 40  28.7 Male 
Participant B 31  28.3 Female 
Participant C 40  27.2 Female 
Participant D 34  24.1 Male 
Participant E 30  27.3 Female 
Participant F 25  25.4 Female 
BMI calculated from self-reported height and weight at time of enrolment. 
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4.2. Independent results 
4.2.1. Participant A 
Participant A was male, aged 40 with a self-reported BMI of 28.7 kg/m2 at recruitment and a 
measured BMI of 30.84 kg/m2. Participant A received a fixed-height standing workstation at the 
commencement of the phase-in period on day 28, which was adjusted for comfort at installation. 
The intervention period commenced on day 56 and participation was completed on day 149 (108 
weekdays). Data are missing for biochemical variables at data point 4 of 6 (day 92). A total of 68 
days of Actigraph data were captured. Due to Actigraph device failure, data are missing between 
days 78 and 108 of the intervention period. 
A meaningful decrease with a ‘very large’ effect size (d = 3.34) in waist circumference was noted 
between baseline (M = 102.5 cm, SD = 2.12) and intervention (M = 97.3 cm, SD = 1.15) which 
exceeded the error of measurement (Figure 4.2.1). A ‘very large’ effect (d = 1.87) was also observed 
for BMI from 30.1 kg/m2 (SD = 1.03) to 28.7 kg/m2 (SD = 0.25). A ‘very large’ meaningful effect was 
also observed in triglycerides (d = 3.61) from baseline (M = 2.7 mmol/l, SD = 0.42) to intervention (M 
= 1.4 mmol/l, SD 0.28) (Figure 4.2.1). Changes in systolic blood pressure, diastolic blood pressure, 
glucose and HDL cholesterol were not meaningful as they did not exceed the error of measurement. 
No significant regression relationships were detected for anthropometric or biochemical markers. 
Following the introduction of the standing workstation daily standing time increased and daily 
sitting time decreased (Figure 4.2.2). Daily standing time increased from baseline (M = 88.4 min, SD 
= 35.8) to the phase in period (M = 248 min, SD = 128) and increased again in the intervention period 
(M = 335 min, SD = 100). A ‘very large’ effect size (d = 3.2) for the change in daily standing (mins) 
over time (days) was observed between the baseline and intervention periods, with a significant 
regression relationship of (F(1,66) = 38.9, p = .0001), with an R2 of 0.37. The daily standing time 
remained consistent for the duration of the intervention study, with no significant non-zero 
regression trend identified. 
Daily sitting time also changed from the baseline (M = 444 min, SD = 67.8) to phase-in (M = 273 
min, SD = 121), with further decrease in sitting in the intervention period (M = 215 min, SD = 102). A 
‘very large’ effect size (d = 2.64) for the decrease in daily sitting (mins) over time (days) was 
observed, with a regression relationship of (F(1,66) = 30.9, p = .0001), with an R2 of 0.32. The daily 
sitting time remained consistent for the duration of the intervention study, with no significant non-
zero regression trend found. 
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C 
 
Figure 4.2.1 – Participant A anthropometry and biochemistry 
A. Between-phase trend of waist circumference and BMI between baseline and intervention 
B. Between-phase trend of systole and diastole blood pressure between baseline and intervention 
C. Between-phase trend of biochemistry between baseline and intervention 
The dotted lines denote commencement of phase-in and intervention periods. Error bars shown where known or visible 
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Figure 4.2.2 – Participant A inclinometry 
A. Within-phase and between-phase trend of waist circumference and BMI between baseline and intervention 
B. Within-phase and between-phase trend of systole and diastole blood pressure between baseline and intervention 
The dotted lines denote commencement of phase-in and intervention periods 
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4.2.2. Participant B 
Participant B was female, aged 31 with a self-reported BMI of 28.3 kg/m2 at recruitment and a 
measured BMI of 28.6 kg/m2. Participant B received a fixed-height standing workstation at the 
commencement of the phase-in period on day 29, which was adjusted for comfort at installation. 
The intervention period commenced on day 57 and participation was completed on day 150 (109 
weekdays). No data are missing for anthropometric or biochemical variables. A total of 86 days of 
Actigraph data were captured with no device failure occurring. 
A meaningful decrease with a ‘very large’ effect size (d = 5.21) in waist circumference was noted 
between baseline (M = 88 cm, SD = 1.41) and intervention (M = 81.3 cm, SD = 1.15) which exceeded 
the error of measurement (Figure 4.2.3). A ‘very large’ effect (d = 2.94) was also observed for BMI 
from 28.6 kg/m2 (SD = 0.03) to 28.2 kg/m2 (SD = 0.19). Changes in systolic blood pressure, diastolic 
blood pressure, glucose, triglycerides and HDL cholesterol were not meaningful as they did not 
exceed the error of measurement. No significant regression relationships were detected for 
anthropometric or biochemical markers. 
Following the introduction of the standing workstation daily standing time increased and daily 
sitting time decreased (Figure 4.2.4). Daily standing time increased from baseline (M = 113 min, SD = 
56.4) to the phase in period (M = 251 min, SD = 64.1) and increased again in the intervention period 
(M = 280 min, SD = 75.8). A ‘very large’ effect size (d = 2.5) for the change in daily standing (mins) 
over time (days) was observed between the baseline and intervention periods, with a significant 
regression relationship of (F(1,84) = 22.9, p = .0001), with an R2 of 0.21. The daily standing time 
remained consistent for the duration of the intervention study, with no significant non-zero 
regression trend found. 
Daily sitting time also changed from the baseline (M = 455 min, SD = 59) to phase-in (M = 320 min, 
SD = 73.6), with further decrease in sitting in the intervention period (M = 295 min, SD = 67.5). A 
‘very large’ effect size (d = 2.52) for the decrease in daily sitting (mins) over time (days) was 
observed, with a regression relationship of (F(1,84) = 25.1, p = .0001), with an R2 of 0.23. The daily 
sitting time remained consistent for the duration of the intervention study, with no significant non-
zero regression trend found. 
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Figure 4.2.3 – Participant B anthropometry and biochemistry 
A. Between-phase trend of waist circumference and BMI between baseline and intervention 
B. Between-phase trend of systole and diastole blood pressure between baseline and intervention 
C. Between-phase trend of biochemistry between baseline and intervention 
The dotted lines denote commencement of phase-in and intervention periods. Error bars shown where known or visible 
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Figure 4.2.4 – Participant B inclinometry 
A. Within-phase and between-phase trend of daily standing time (mins) between baseline and intervention 
B. Within-phase and between-phase trend of daily sitting time (mins) between baseline and intervention 
The dotted lines denote commencement of phase-in and intervention periods 
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4.2.3. Participant C 
Participant C was female, aged 40 with a self-reported BMI of 27.2 kg/m2 at the start of the study. 
Participant C received an electric sit-stand desk at the commencement of the phase-in period on 
day 38, the intervention period commenced on day 66 and participation was completed on day 172 
(125 weekdays). Data are missing for anthropometric variables at data point 4 of 6 (day 101) and 
biochemical variables at data point 3 (day 73) and data point 4 (day 101). A total of 73 days of 
Actigraph data were captured. Due to Actigraph device failure, inclinometry data are missing 
between days 78 and 121 of the intervention period. At the completion of the study the participant 
purchased the sit-stand workstation. 
A meaningful decrease with a ‘very large’ effect size (d = 2.24) in waist circumference was noted 
between baseline (M = 77.5 cm, SD = 0.71) and intervention (M = 75 cm, SD = 1.41) which exceeded 
the error of measurement (Figure 4.2.5). A ‘very large’ effect (d = 2.94) was also observed for the 
increase of BMI from 25 kg/m2 (SD = 0.24) to 25.5 kg/m2 (SD = 0.06). Changes in systolic blood 
pressure, diastolic blood pressure, glucose, triglycerides and HDL cholesterol were not meaningful 
as they did not exceed the error of measurement. No significant regression relationships were 
detected for anthropometric or biochemical markers.  
Following the introduction of the standing workstation daily standing time increased and daily 
sitting time decreased (Figure 4.2.6). Daily standing time increased from baseline (M = 187 min, SD 
= 78.9) to the phase in period (M = 260 min, SD = 77) and increased again in the intervention period 
(M = 298 min, SD = 96.3). A ‘very large’ effect size (d = 1.26) for the change in daily standing (mins) 
over time (days) was observed between the baseline and intervention periods, with a significant 
regression relationship of (F(1,71) = 20, p = .0001), with an R2 of 0.22. The daily standing time 
remained consistent for the duration of the intervention study, with no significant non-zero 
regression trend found. 
Daily sitting time also changed from the baseline (M = 381 min, SD = 93.6) to phase-in (M = 313 
min, SD = 83.1), with further decrease in sitting in the intervention period (M = 269 min, SD = 90.1). 
A ‘very large’ effect size (d = 1.22) for the decrease in daily sitting (mins) over time (days) was 
observed, with a regression relationship of (F(1,71) = 21, p = .0001), with an R2 of 0.23. During the 
intervention period there was a significant negative trend towards decreased daily standing time 
(F(1,27) = 6, p = .02), with an R2 of 0.18. During the intervention period there was a significant 
negative trend towards decreased daily standing time (F(1,27) = 6, p = .002), with an R2 of 0.18. 
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Figure 4.2.5 – Participant C anthropometry and biochemistry 
A. Between-phase trend of waist circumference and BMI between baseline and intervention 
B. Between-phase trend of systole and diastole blood pressure between baseline and intervention 
C. Between-phase trend of biochemistry between baseline and intervention 
The dotted lines denote commencement of phase-in and intervention periods. Error bars shown where known or visible 
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Figure 4.2.6 – Participant C inclinometry 
A. Within-phase and between-phase trend of daily standing time (mins) between baseline and intervention 
B. Within-phase and betweeb-phase trend of daily sitting time (mins) between baseline and intervention 
The dotted lines denote commencement of phase-in and intervention periods 
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4.2.4. Participant D 
Participant D was male, aged 34 with a self-reported BMI of 24.1 kg/m2 at recruitment and a 
measured BMI of 24.6 kg/m2. Participant D received an electric sit-stand workstation at the 
commencement of the phase-in period on day 27, which was adjusted for comfort at installation. 
The intervention period commenced on day 55 and the participant withdrew on day 90 (65 
weekdays) due to geographical relocation. No data are missing for anthropometric or biochemical 
variables during participation; however, due to withdrawal only 1 data point is available in the 
intervention period. A total of 44 days of Actigraph data were captured, with missing data 75 and 80 
of the intervention period. At the completion of the study the participant purchased the sit-stand 
workstation. 
A meaningful increase with a ‘very large’ effect size (d = 1.67) in blood glucose was noted between 
baseline (M = 5.15 mmol/L, SD = 0.64) and intervention (M = 5.9 mmol/L, SD = 0) which exceeded 
the error of measurement (Figure 4.2.7). Changes in waist circumference, BMI, systolic blood 
pressure, diastolic blood pressure, triglycerides and HDL cholesterol were not meaningful as they 
did not exceed the error of measurement. No significant regression relationships were detected for 
anthropometric or biochemical markers. 
Following the introduction of the standing workstation daily standing time increased and daily 
sitting time decreased (Figure 4.2.8). Daily standing time increased from baseline (M = 147 min, SD 
= 118) to the phase in period (M = 190 min, SD = 58.6) and increased again in the intervention period 
(M = 267 min, SD = 77.9). A ‘very large’ effect size (d = 1.20) for the change in daily standing (mins) 
over time (days) was observed between the baseline and intervention periods, with a significant 
regression relationship of (F(1,42) = 8.98, p = .0046), with an R2 of 0.18. The daily standing time 
remained consistent for the duration of the intervention study, with no significant non-zero 
regression trend found. 
Daily sitting time also changed from the baseline (M = 395 min, SD = 124) to phase-in (M = 359 min, 
SD = 73.4), with further decrease in sitting in the intervention period (M = 288 min, SD = 79.2). A 
‘very large’ effect size (d = 1.03) for the decrease in daily sitting (mins) over time (days) was 
observed, with a regression relationship of (F(1,42) = 4.81, p = .034), with an R2 of 0.1. The daily 
sitting time remained consistent for the duration of the intervention study, with no significant non-
zero regression trend found. 
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Figure 4.2.7 – Participant D anthropometry and biochemistry. 
A. Between-phase trend of waist circumference and BMI between baseline and intervention 
B. Between-phase trend of systole and diastole blood pressure between baseline and intervention 
C. Between-phase trend of biochemistry between baseline and intervention 
The dotted lines denote commencement of phase-in and intervention periods. Error bars shown where known or visible. 
D a y  n u m b e r
W
a
is
t 
c
ir
c
u
m
fe
re
n
c
e
 (
c
m
)
B
M
I (k
g
/m
2
)
0 5 0 1 0 0 1 5 0
7 0
8 0
9 0
1 0 0
2 3
2 4
2 5
2 6
2 7
W a is t  C ir c u m f e r e n c e B M I
D a y  n u m b e r
B
lo
o
d
 P
re
s
s
u
re
 (
m
m
/H
G
)
0 5 0 1 0 0 1 5 0
0
5 0
1 0 0
1 5 0
D ia s t o l e S y s t o le
D a y
C
o
n
c
e
n
tr
a
ti
o
n
 (
m
m
o
l/
L
)
0 2 0 4 0 6 0 8 0 1 0 0
0
2
4
6
G l u c o s e
T r ia c y lg ly c e r o l
H D L  C h o le s t e r o l
 60 
 
 
  
  
A 
 
B 
 
Figure 4.2.8 – Participant D inclinometry. 
A. Within-phase and between-phase trend of daily standing time (mins) between baseline and intervention 
B. Within-phase and between-phase trend of daily sitting time (mins) between baseline and intervention 
The dotted lines denote commencement of phase-in and intervention periods. 
D a y s
D
a
il
y
 t
o
ta
l 
s
ta
n
d
in
g
 (
m
in
s
)
0 2 0 4 0 6 0 8 0 1 0 0
0
2 0 0
4 0 0
6 0 0
D a y s
D
a
il
y
 t
o
ta
l 
s
it
ti
n
g
 (
m
in
s
)
0 2 0 4 0 6 0 8 0 1 0 0
0
2 0 0
4 0 0
6 0 0
 61 
 
4.2.5. Participant E  
Participant E was female, aged 30 with a self-reported BMI of 27.3 kg/m2 at recruitment and a 
measured BMI of 32.71 kg/m2. Participant E received an electric sit-stand workstation at the 
commencement of the phase-in period on day 39, which was adjusted for comfort at installation. 
The intervention period commenced on day 69 and participation was completed on day 164 (119 
weekdays). Anthropometry data are missing for data point 5 of 6 (day 149) and biochemical data 
are missing for data point 3 (day 81) and data point 5 (day 149). The final biochemical data collection 
was taken at day 207, 43 days after completion. Due to a fault no Actigraph data are available for 
the entire period of the study. At the completion of the study the participant purchased the sit-
stand workstation. 
No meaningful changes were detected for waist circumference, BMI, systolic blood pressure, 
diastolic blood pressure, glucose, triglycerides and HDL cholesterol as they did not exceed the error 
of measurement. No significant regression relationships were detected for anthropometric or 
biochemical markers. 
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Figure 4.2.9 – Participant E anthropometry and biochemistry. 
A. Inter-phase trend of waist circumference and BMI between baseline and intervention 
B. Inter-phase trend of systole and diastole blood pressure between baseline and intervention 
C. Inter-phase trend of biochemistry between baseline and intervention 
The dotted lines denote commencement of phase-in and intervention periods. Error bars shown where known or visible. 
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4.2.6. Participant F  
Participant F was female, aged 25 with a self-reported BMI of 25.4 kg/m2 at recruitment and a 
measured BMI of 27.2 kg/m2. Participant F received an electric sit-stand workstation at the 
commencement of the phase-in period on day 37, which was adjusted for comfort at installation. 
The intervention period commenced on day 65 and the participant withdrew on day 129 (94 
weekdays) due to geographical relocation. No data are missing for anthropometric or biochemical 
variables during participation; however, due to withdrawal only 1 data point is available in the 
intervention period. A total of 75 days of Actigraph data were captured, with no device failure. 
An increase with a ‘very large’ effect size (d = 4.83) in BMI was noted between baseline (M = 27 
kg/m2, SD = 0.24) and intervention (M = 28.4 kg/m2, SD = 0.33) (Figure 4.2.10). Changes in waist 
circumference, systolic blood pressure, diastolic blood pressure, blood glucose, triglycerides and 
HDL cholesterol were not meaningful as they did not exceed the error of measurement. No 
significant regression relationships were detected for anthropometric or biochemical markers. 
Following the introduction of the standing workstation daily standing time increased and daily 
sitting time decreased (Figure 4.2.11). Daily standing time increased from baseline (M = 99.8 min, 
SD = 67.6) to the phase in period (M = 224 min, SD = 103) and increased again in the intervention 
period (M = 441 min, SD = 72). A ‘very large’ effect size (d = 4.45) for the change in daily standing 
(mins) over time (days) was observed between the baseline and intervention periods, with a 
significant regression relationship of (F(1,73) = 183, p = .0001), with an R2 of 0.72. During the 
intervention period there was a significant positive trend towards increasing daily standing time 
(F(1,37) = 6.83, p = .0129), with an R2 of 0.15. 
Daily sitting time also changed from the baseline (M = 487 min, SD = 68.4) to phase-in (M = 363 
min, SD = 108), with further decrease in sitting in the intervention period (M = 176 min, SD = 68.8). A 
‘very large’ effect size (d = 4.53) for the decrease in daily sitting (mins) over time (days) was 
observed, with a regression relationship of (F(1,73) = 185, p = .034), with an R2 of 0.72. During the 
intervention period there was a significant negative trend towards decreased daily standing time 
(F(1,37) = 8.95, p = .0049), with an R2 of 0.19. 
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Figure 4.2.10 – Participant F anthropometry and biochemistry. 
A. Between-phase trend of waist circumference and BMI between baseline and intervention 
B. Between-phase trend of systole and diastole blood pressure between baseline and intervention 
C. Between-phase trend of biochemistry between baseline and intervention 
The dotted lines denote commencement of phase-in and intervention periods. Error bars shown where known or visible. 
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Figure 4.2.11 – Participant F inclinometry. 
A. Within-phase and between-phase trend of daily standing time (mins) between baseline and intervention 
B. Within-phase and between-phase trend of daily sitting time (mins) between baseline and intervention 
The dotted lines denote commencement of phase-in and intervention periods. 
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5.1. Findings 
The aims of this study were to assess the impact of using standing workstations to reduce 
occupational sitting time and measure any potential changes in the markers of MetS. Six office 
workers participated for a total of 620 weekdays, over which time a total of 31 anthropometric and 
27 biochemical data points were collected. A total of 346 weekdays of occupational inclinometry 
data were collected across 5 participants, with device failure resulting in no inclinometry data being 
available for 1 participant. 
Following the introduction of a sit-stand or standing workstation, changes were seen for 
objectively measured daily occupational standing time and sitting time for 5 participants between 
the baseline and intervention periods. The minimum increase in daily standing was 111 min/day and 
the maximum increase in daily standing was 341 min/day. The minimum decrease in daily 
occupational sitting was 107 min/day and the maximum was 311 min/day. These reductions in daily 
sitting and increases in daily standing were maintained during the entire intervention period by all 
participants. Even where participants had the option to sit down, either on the provided stools or, 
where available, by lowering their electric height-adjustable desk, participants still chose to stand 
for long periods of time. 
Changes were observed for some markers of MetS in some participants. A meaningful decrease 
that exceeded measurement error was observed for waist circumference in three participants 
between the baseline and intervention periods. The smallest change was a decrease in waist 
circumference of 2.5 cm and the largest change was a decrease of 6.7 cm. Change was also seen for 
BMI with two participants experiencing a decrease and two participants experiencing an increase. 
Finally, some changes in biochemical markers were seen, with one participant experiencing a 
decrease in blood triglyceride concentration of 1.3 mmol/L between baseline and intervention. An 
increase in blood glucose concentration was seen in one participant of 0.75 mmol/L between 
baseline and intervention. 
The failure to detect meaningful change in the metabolic markers for the participants might be 
explained by the complex processes involved in the development MetS, as well as the limitations of 
this study. While an increase in standing time may produce higher energy expenditure, it may be 
that the 13 week intervention duration of this study was not long enough to capture a change 
exceeding the natural variation. As this study did not monitor or adjust for physical activity or diet, it 
may be that these influences negated any beneficial impact experienced through a reduction of 
sedentary behaviour. MetS development is likely comprised of a number of environmental changes 
including quantity and nutritional content of food selection and a decrease of light, moderate and 
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vigorous intensity physical activity. It is possible that the use of standing desks may be 
complimentary to a larger environmental intervention program that incorporates dietary and 
physical activity modification. Nonetheless, it may be that with an extended intervention period 
and control or statistical modelling to adjust for food and exercise, changes to MetS markers may 
become more apparent. 
Attempts were made to provide some control through recommendations to maintain diet and 
exercise. While this may have produced mild reduction to the effects of external variables, such as 
participants engaging in new sports, it potentially increases risk for participants. A recommendation 
to maintain a 6 month average dietary intake and level of physical activity may produce a barrier to 
health for participants who have an excuse to avoid lifestyle interventions. Instead, it is suggested 
that future studies attempt to monitor for diet, moderate and vigorous physical activity as well as 
leisure time sedentary behaviour in order to produce adjusted models for statistical analysis that 
might provide far more accurate appraisal of any changes. 
The increase in daily standing and decrease in daily sitting may have been attributable to the 
‘novelty’ of the new equipment, as well as a desire to succeed under observation. This might have 
been reinforced if participants returned to their baseline sitting and standing levels as the novelty of 
the intervention dissipated. Where results were available from Actigraph data, all participants 
displayed a consistent stability in the intervention period standing and sitting times, with one 
participant showing a significant regression trend towards continuing increases in daily standing 
and two participants showing a significant trend towards further decreases in sitting time. This 
stability towards decreased sedentary behaviour is encouraging; however, these results cannot be 
generalised for long periods and longer term changes may be different to that observed in this 
study. 
Changes in sedentary behaviour observed during the study reflect the findings of similar studies. 
Alkhajah et al. (2012) showed that the use of a sit-stand workstation in office workers (n=32) 
decreased occupational sitting by 143 min/day (95% CI = -184 to -102) with participants maintaining 
reductions in sitting and increases in standing after 3 months. Similary changes in sedentary 
behaviour were also seen by Neuhaus et al. (2014) where participants in standing workstation 
groups decreased their total daily sitting time by between 33 and 89 min/day.  
The lack of metabolic change is also reflected in similar studies. While Buckley et al. (2014) 
showed that postprandial blood glucose levels were lower following periods of standing, they failed 
to observe a significant decrease in overnight blood glucose levels between sitting and standing 
participants. Equally, Alkhajah et al. (2012) saw an increase in HDL cholesterol following the 
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introduction of a standing workstation; however, no changes were observed for blood glucose or 
triglycerides following a 3 month intervention period. While there is evidence in these studies that 
metabolic changes can occur through the use of a standing workstation, as seen in decreased 
postprandial blood glucose and increased HDL cholesterol, it may be that the intervention period 
was too short to observe long term change. 
The outcomes of this study provide preliminary and low-level evidence that the use of a sit-stand 
or standing workstation can reduce occupational sedentary behaviour and increase occupational 
standing time. Sedentary behaviour is associated with detrimental changes to the markers of MetS 
(Healy, Wijndaele, et al., 2008) as well as an increased risk for CVD and all-cause mortality 
(Stamatakis et al., 2011) that is independent of physical activity levels. Therefore, concern for the 
welfare of office based workers may be addressed by reducing sedentary behaviour through 
replacement with light-intensity physical activity, such as standing (Healy et al., 2007).  
5.2. Limitations of this study 
Some limitations were experienced that may have affected the outcome variables. Many of the 
markers of MetS are subject to natural variability over short and long periods of time. Blood 
pressure is dynamic and modulated by daily occupational stress, coffee and stimulant intake or 
simply through the process of measurement (Parati, Ochoa, Lombardi, & Bilo, 2013). Natural 
variation of blood pressure (Parati et al., 2013), biochemical markers (Demacker et al., 1982; Widjaja 
et al., 1999), weight and even height (Lohmann, Roche, & Martorell, 1988) has been well 
documented. Analysis included natural errors where known, so that only changes exceeding these 
natural variations were considered to be meaningful. However, it is likely that although not visible in 
the results, variations of individual markers that did not exceed the measurement error have 
influenced any anthropomorphic or biochemical changes in participants during this study. 
Additionally, some changes may occur through seasonal variation in diet or changes to physical 
activity, which may not have been captured accurately due to the short time-frame of this study. 
Due to the exploratory nature of this pilot study, participants were not required to maintain physical 
activity or food diaries which may be useful in subsuequent studies. While this study avoided the 
New Zealand summer holiday period, it may be that the effects of of several weeks of altered 
behaviour may produce long lasting results. Equally, as this study occurred across autumn and 
winter months, there may have been changes to dietary patterns as a result of colder weather and 
shorter daylight hours. 
 A major contributing factor in the limitations of this study were the financial and time costs 
associated with regular sampling and laboratory charges. Difficulties with participant scheduling 
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due to work constraints meant that in many cases sampling of anthropometric markers was delayed 
or occurred at sub-optimal periods. The delays of data collection may have been mitigated by 
collecting anthropometric data alongside biochemical data following a period of fasting. 
There were repeated failures in Actigraph inclinometry data due to battery depletion and device 
failure. Due to the 4 week interval between downloads, any device failure that occurred during this 
time was not identifiable until the next collection point. Battery depletion occurred in three devices 
resulting in 74 days of missing data. Although battery chargers and instruction sheets were provided 
to participants, the LED indicator on the device was regularly concealed under clothing and might 
have been difficult to notice. One Actigraph was faulty, resulting in up to 119 days of unusable data 
which was only realised at the end of the study. These errors could have been avoided with 
improved participant training so that a low battery fault could be rectified before device shut-down. 
Additionally, more vigorous device testing prior to study and frequent integrity checks of captured 
data may have identified the faulty device earlier. Data monitoring in field-based studies is desirable 
to ensure good quality data and minimisation of missing data points; however, monitoring also 
involves investigator time and cost that were beyond the scope of the current study. 
5.3. Recommendations for future studies 
The results of this study provide sufficient evidence to justify future research that examine the 
effects of sit-stand or standing workstations on the levels of sedentary behaviour in sedentary office 
workers. Further, there is enough supporting evidence to suggest that although only small changes 
were seen in the MetS markers, a sound basis of research supports the idea that decreasing 
sedentary behaviour may provide a positive impact on metabolic health. 
Recommendations for future research include changes to study design, size, duration and data 
analysis. A large sample randomised-controlled study, over a longer period of time, would allow for 
selection of participants across a wider range of demographics and health status. A larger sample 
would also allow for a greater comparison between the results of a sit-stand intervention group and 
a sitting only group. During the course of this study it was learned through anecdotal sources that 
several Auckland based companies undertook office retrofits and introduced sit-stand workstations 
on a company-wide basis. A research study integrating with an office retrofit may provide an 
economically efficient opportunity for investigators by reducing study expenses as well as gaining 
access to a larger sample. 
An increased number of breaks in sedentary time, such as standing up for at least 1 minute, may 
be associated with improved blood glucose, waist circumference and HDL cholesterol (Healy, 
Dunstan, et al., 2008). Future studies should investigate the patterns of sedentary and standing 
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time as a result of the implementation of standing desks. The use of accelerometers and 
inclinometers provides for in depth analysis of occupational sedentary behaviour patterns. Through 
the use of a larger sample, future research may also provide a cross-sectional analysis of the New 
Zealand sedentary behaviour profile, such as occupational sitting time, average time spent sitting or 
standing or the change in behaviour throughout the day and week. This information may allow aid 
in education programs or to develop intervention strategies. 
Future researcher may choose to investigate non traditional markers of metabolic syndrome in 
addition to those classified under WHO, ATPIII, EGIR or criteria decribed by the International 
Diabetes Federation. For example, an investigation examining changes found in LDL particle size, 
systemic pro-inflammatory markers such as C-reactive protein, adipocyte macrophage population 
or lipoprotein lipase activity may discover important changes following the reduction of sedentary 
behaviour. As the metabolic syndrome is poorly understood, research of this nature may assist the 
international community to better unsderstand how sedentary behaviour impacts the wide array of 
metabolic disturbances that occur in people experiencing MetS, T2DM and CVD.  
Learnings from field-notes made during this study may also assist future researchers. Efficient 
organisation and planning of data collection points may help to reduce missed appointments with 
participants. Additionally, the use of a central data collection point, such as a laboratory, where 
participants can be assessed may reduce the time costs associated with data collectors visiting 
individual participants. Additionally, visits to participants may help to ensure that anthropometric 
or biochemical data are all captured at optimal times, such as first thing in the morning before 
breakfast or caffeine intake. Researchers may find that regular checks of inclinometer or 
accelerometer devices and captured data will reduce the likelihood of lost data. Where possible, 
replacement of participant furniture might be done by the manufacturing and supplying company 
at the time of delivery, in order to minimise delay and reduce researcher demands. 
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